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ABSTRACT

Conversion between two growth stages, tachyzoites and bradyzoites, plays a key
role in the pathogenesis of Toxoplasma gondii. Current studies aimed to elucidate the
roles of lactate dehydrogenase (TgLDH) and argonaute (TgAgo) in relation to conversion.
The over-expression of TgLDH1 or TgLDH2 did not change the overall enzymatic
activity or increase growth of tachyzoites. However, a significant in vitro differentiation
into bradyzoites was detected. These findings suggest that TgLDH1 and TgLDH2 have
important physiological functions, in addition to being glycolytic enzymes and
differentiation markers. Furthermore, altered TgAgo expression increased bradyzoite
formation and interfered with the parasite’s ability to successfully perform double
stranded induced gene silencing. The change in TgAgo expression also affected the
levels of putative dicer proteins suggesting a direct correlation between TgAgo and an
RNAi-like mechanism.
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Chapter I
Introduction

1.1

Significance of Toxoplasma gondii and disease
Toxoplasma gondii is an intracellular protozoan parasite and a member of the

Apicomplexa phylum, which is characterized by the presence of apical secretory
organelles including micronemes, rhoptries, and dense granules (Dubey et al., 1998). T.
gondii causes significant disease in a variety of mammals and birds and is known to infect
approximately one third of the world’s population, which may lead to the development of
toxoplasmosis.
T. gondii infections can be acquired either through ingestion of viable tissue cysts
in under-cooked meat or through ingestion of water contaminated with oocysts from
infected cat faeces (Frenkel, 1973; Dubey et al, 1970). Initial infection of individuals
with a healthy immune system, are normally asymptomatic because the rapidly
multiplying tachyzoite stage of the parasite can be cleared by the host immune response.
When infection is acquired during pregnancy however, in utero toxoplasmosis can occur,
resulting in harm to the fetus such as abortion, severe birth defects, or fetal death
(Guerina et al., 1994). Tachyzoites can undergo a stage interconversion into the slowly
multiplying, encysted bradyzoites, which can remain dormant for the lifespan of the host,
causing chronic toxoplasmosis (Ferguson et al., 2002; Lindsay et al., 1991).
Toxoplasmosis can prove fatal when infected patients become immuno-compromised,
such as HIV/AIDS patients (Wong and Remington, 1993; Luft and Remington, 1992),
1

wherein the bradyzoites are released from the tissue cysts and differentiate back into
tachyzoites giving rise to a recurrent infection and making this an opportunistic parasite.
The ability of the parasite to interconvert between these two stages is thought to play a
key role in the pathogenesis of the parasite. The process of interconversoin in humans
and other non-definitive hosts is poorly understood (Reiter-Owona et al., 2000). To date,
no effective treatment for chronic toxoplasmosis has been developed. Therefore, studies
of T. gondii in cell culture facilitate the search for possible drug targets and the
development of preventative strategies and therapeutic agents for toxoplasmosis.

1.2

Toxoplasma gondii as an apicomplexan model
The apicomplexan parasites include many pathogenic protozoans, such as

Plasmodium and Cryptosporidium, which cause a variety of diseases in humans. For
instance, the Plasmodium parasite is known to infect human red blood cells causing
malaria, a serious and possibly fatal disease (Cowman and Crabb, 2002), while
Cryptosporidium causes a diarrhoeal illness called cryptosporidiosis that is also
associated with immuno-compromised individuals (Abrahamsen et al., 2004). Studies of
these parasites have proven challenging due to the difficulty of culturing and maintaining
them in the laboratory. T. gondii however, is the most experimentally tractable parasite
since it is easily propagated and cultured (Kim and Weiss, 2004). Thus, T. gondii has
become a major model for the study of apicomplexans due to the ease of genetically
manipulating the parasite for the study of basic biology and host response (Roos et al.,
1994; Black and Boothroyd, 1998). The 80 Mb haploid genome of T. gondii consists of
14 chromosomes.

Recent sequencing projects have provided a great amount of
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information that has been deposited into the T. gondii database further enhancing research
efforts (ToxoDB: http://www.toxodb.org; Kissinger et al., 2003).

1.3

Genetic manipulations of Toxoplasma gondii
A variety of tools have been developed for genetically manipulating T. gondii,

thus enhancing the study of gene functions and molecular events. In order to introduce
DNA and RNA into T. gondii, electroporation has become a method of choice, in which
an electric current is applied to the parasite creating pores in the membrane, allowing for
the nucleic acids to be incorporated.

1.3.1 Transient and stable transfections
Transient gene expression occurs when the transforming plasmid lacks a T. gondii
origin of replication, or fails to be maintained in the genome resulting in gene expression
that lasts for a short amount of time (Roos et al., 1994). Reporter genes such as βgalactosidase (LacZ), chloramphenicol acetyltransferase (CAT), and luciferase (Luc)
have been employed to indicate that the plasmid introduction was successful, with highest
efficiency occurring when the expression is driven by T. gondii promoters such as those
of surface antigens, rhoptry proteins, and β-tubulin (Roos et al., 1994; Soldati and
Boothroyd, 1995).
Stable transformation, on the other hand, results from either homologous or
random integration of the transgenes, and leads to parasites that permanently express the
selectable marker. Transformation vectors containing sequences from the dihydrofolate
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reductase-thymidylate synthase gene (DHFR-TS) have been developed for random
integration (Donald and Roos, 1994).

1.3.2

Endogenous selectable markers for stable transfections

There are a variety of selectable markers that can be used for generating stable
transformants. Two important selectable markers that are highly utilized in the present
studies include the hypoxanthine-xanthine-guanine phosphoribosyltransferase (HXGPRT)
and uracil phosphoribosyltransferase (UPRT) genes, which are part of the purine and
pyrimidine pathways, respectively, and provide the substrates for DNA and RNA
biosynthesis (Iltzsch, 1993; Chaudhary et al., 2004).

1.3.2.1

Hypoxanthine-xanthine-guanine
phosphoribosyltransferase

Similar to many intracellular pathogens, T. gondii does not contain a de novo
purine nucleotide biosynthesis pathway. Therefore, the parasite relies on the purine
salvage pathway to provide purine nucleotides that are required for growth (Krug et al.,
1989).

Hypoxanthine-xanthine-guanine phosphoribosyltransferase (HXGPRT, E.C.

2.4.2.8), an essential gene of the purine salvage pathway, catalyzes the conversion of
hypoxanthine, xanthine, and guanine into inosine monophosphate (IMP), xanthine
monophosphate (XMP), and guanine monophosphate (GMP), respectively (Fig. 1.1). In
the absence of HXGPRT or xanthine, IMP dehydrogenase can synthesize XMP. When
utilizing HXGPRT as a positive selectable marker; mycophenolic acid (MPA) and
xanthine are added to the culture media. IMP dehydrogenase is inhibited by MPA, thus
synthesis of XMP and GMP, which is required for parasite survival, is prevented.
4

However, parasites containing HXGPRT can utilize the added xanthine to synthesize
XMP and survive.

Therefore, parasites lacking the HXGPRT gene, RHΔHX, are

electroporated with plasmids containing the HXGPRT gene and therefore, only parasites
that incorporate and express HXGPRT can survive under MPA and xanthine selection.
Furthermore, HXGPRT can also be utilized for negative selection. In this case, HXGPRT
catalyzes the conversion of 6-thioxanthine (6-TX) in the media, into 6-thioxanthosine-5’phosphate, which causes toxicity to the parasite, thus only parasites that lack the
HXGPRT gene can survive (Chaudhary et al., 2004; Donald and Roos, 1993).

5

Figure 1.1
Purine salvage pathway of Toxoplasma gondii. The dominant enzymes
of the purine salvage pathways are adenosine kinase (AK) and hypoxanthine-xanthineguanine phosphoribosyltransferase (HXGPRT). The other enzymes are numbered: (1)
adenosine deaminase; (2) purine nucleoside phosphorylase; (3) adenine deaminase; (4)
AMP deaminase; (5) IMP dehydrogenase; (6) GMP synthetase; (7) adenylosuccinate
synthetase; (8) adenylosuccinate lyase. HC represents host cell cytoplasm; PV refers to
the parasitophorous vacuole; PC refers to the protist cytoplasm. This image was modified
from Chaudhary et al., 2004.

6

1.3.2.2

Uracil phosphoribosyltransferase

Uracil phosphoribosyltransferase (UPRT, E.C. 2.4.2.19) is an enzyme responsible
for the incorporation and conversion of uracil into uracil monophosphate (UMP) in the
pyrimidine salvage pathway (Fig. 1.2) (Schwartzman and Pfefferkorn, 1981). Since T.
gondii is capable of synthesizing pyrimidines de novo, UPRT is not an essential enzyme
for the parasite. UPRT has the ability to recognize pyrimidines, as well as cytotoxic
analogs of pyrimidines. Thus, UPRT can also incorporate and convert 5-fluorouracil into
5-fluorouridine which is further synthesized into 5-fluorouridine monophosphate (FdUMP) which prevents the synthesis of thymidine monophosphate, resulting in lethality
to the parasite (Iltzsch and Tankersley, 1994). Generation of parasites lacking the UPRT
gene allows for survival, since the 5-fluorouracil cannot be incorporated and metabolized.
Mammalian cells do not have the ability to take up uracil from the media, therefore
studies involving UPRT can also be utilized for measuring the parasite’s ability to
incorporate radioactively labelled uracil, [5,6-3H]-uracil in order to measure viability
(Pfefferkorn and Pfefferkorn, 1977) and gene regulation (Al-Anouti et al., 2003).

7

Figure 1.2
De novo pyrimidine biosynthesis and pyrimidine salvage pathways of
Toxoplasma gondii. The synthesis of UMP, the precursor for pyrimidines, is shown
where the UPRT enzyme (1) is part of the salvage pathway. This image was obtained
from Fox and Bzik, 2002.
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1.4

Toxoplasma gondii parasite types and host cells
Molecular analysis suggests that all currently identified strains of Toxoplasma

gondii can be classified into three common clonal lineages; types I, II, and III (Howe and
Sibley, 1995; Sibley and Boothroyd, 1992). Type I strains, such as RH and GT1, are
highly virulent strains that cause 100% lethality in mice with a single infectious organism
and have a limited ability to form cysts in culture and in animals. Also, Type I strains are
fairly uncommon, where only a small group of congenital toxoplasmosis patients and
opportunistic infections in AIDS patients have been identified. On the other hand, Type
II strains, such as ME49 and PLK, and Type III strains, such as VEG, are less virulent in
mice and cause lethality with more than 1000 parasites. Type II strains have been found
to be the most prevalent strain in clinical isolates and may cause mild infection in healthy
individuals but severe disease in AIDS patients (Khan et al., 2009; Sibley, 2009).
Furthermore, type I strains are commonly used in laboratories for in vitro studies due to
their rapid replication rate and efficiency of lysing host cells, allowing for isolation of
large amounts of tachyzoites.
The proliferative form of the parasite is the tachyzoite, which can be maintained in
many mammalian cells. The infection ability of tachyzoites is greater in adhesive cell
types rather than in suspension cultures, possibly due to the higher probability of contact
between parasites and adherent monolyaers as compared to suspended cells. Therefore,
human foreskin fibroblasts (HFF) are typically used in routine cell culture. HFF cells are
convenient due to their ease of passage and their morphology which consists of a large
plasma membrane allowing for multiple cycles of replication of T. gondii to occur before
lysis. Finally, HFF cells are fairly resistant to metabolic inhibitors due to their inability to

9

grow past confluency, thus allowing for drug selection of transfected parasites (Roos et
al., 1994).

1.5

General cell biology of Toxoplasma gondii

1.5.1

Sexual cycle in the definitive host

Toxoplasma gondii has a complex life cycle involving two phases, the sexual
cycle in the feline definitive host and the asexual cycle in any intermediate host, such as
cattle and humans, which is summarized schematically in Figure 1.3. The sexual cycle
occurs only in intestinal epithelial cells and begins with the feline ingesting tissue cysts
from infected animals such as rats (Frenkel, 1973). The parasites are then released in the
digestive system where they proceed through gametogenesis which consequently leads to
the formation of a diploid zygote known as an oocyst. The oocysts are excreted in the
feces, and upon exposure to oxygen and ambient temperature, sporogony occurs wherein
two meiotic divisions and one mitotic division produce eight haploid sporozoites divided
into two sporocysts which remain stable and infectious for months to a year in the soil,
even in harsh climates (Frenkel, 1973).

1.5.2 Asexual cycle in intermediate hosts
Infectious oocysts in the soil or viable tissue cysts in undercooked meat provide
an entry into humans and animals. Upon entry, the sporozoites or bradyzoites infect the
intestinal epithelium and differentiate into tachyzoites, a process also known as
interconversion. The tachyzoites travel throughout the body via the blood stream, causing
initial infection by T. gondii which is typically asymptomatic or may cause mild flu-like
10

symptoms. The asexual cycle occurs within the host cell where the parasite multiplies by
endodyogeny forming two daughter cells in each division, eventually causing the host cell
to rupture and allowing the parasite to infect neighbouring cells (Sheffield and Melton,
1968; reviewed in Black and Boothroyd, 2000). After the host’s immune response is
triggered, the tachyzoites convert into the slowly multiplying bradyzoites where they are
protected within tissue cysts for the remainder of the host’s lifespan (Ferguson et al.,
2002; Lindsay et al., 1991).

11

Figure 1.3
The life cycle of Toxoplasma gondii. The life cycle of T. gondii consists
of a sexual cycle within intestinal cells of felines, and an asexual cycle that occurs in
mammals, birds, and virtually any nucleated cell. Infection is often acquired through
accidental ingestion of eliminated oocysts. Acute infection is represented by the quickly
replicating tachyzoites, while chronic infection is representative of encysted bradyzoites
that remain dormant for the lifespan of the host. This image was obtained from Dubey,
1986.
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1.5.2.1

Tachyzoites

The asexual cycle of T. gondii consists of two different stages of the parasite
including tachyzoites and bradyzoites, which differ in many aspects. Tachyzoites are the
rapidly dividing form of the parasite which cause initial infection.

They are often

crescent shaped with an approximate length of 6 μm and width of 2 μm. Tachyzoites
have the ability to infect almost any nucleated cell by attaching to the host cell membrane
and directly penetrating the cell where they become encased in the parasitophorous
vacuole (PV) composed of membranes from both the parasite and host cell (Dobrowolski
and Sibley, 1996). The asexual cycle occurs within the host cell where the parasite
multiplies by endodyogeny forming two daughter cells in each division (Sheffield and
Melton, 1968). Tachyzoites continue to replicate until they eventually rupture the host
cell and are released, where they can infect neighboring cells.

1.5.2.2

Bradyzoites

Tachyzoites differentiate into bradyzoites upon a response from the host’s
immune system. Bradyzoites are the slowly multiplying form of the parasite that generate
tissue cysts within the host, defining the chronic stage of infection. Bradyzoite tissue
cysts are commonly found in the central nervous system as well as in the muscles ranging
from a size of 50 μm to 70 μm containing 1000-2000 bradyzoites that are crescent shaped
with a size of 7 μm by 1.5 μm (Dubey et al., 1998; Fortier et al., 1996; Sims et al., 1989).
The cyst wall, composed of ß-(1,4) linked N-acetylglucosamine residues called chitin, a
derivative of glucose, surrounds the bradyzoites and is responsible for protecting the
parasite from the host’s immune response. This cyst wall is easily identified in culture by
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fluorescently labeled lectins in Dolichos biflorus which bind the glycoprotein CST1
(Zhang et al., 2001; Boothroyd et al., 1997).
Ultrastructurally, bradyzoites differ from tachzyoites since brazyzoites have a
posteriorly located nucleus, honeycombed rhoptries, and several amylopectin granules for
glucose storage; whereas tachyzoites have a centrally located nucleus, electron dense
rhoptries and very few amylopectin granules (Ferguson et al., 1987, 1989). Furthermore,
bradyzoites are more slender than tachyzoites, and tachyzoites are more sensitive to
destruction by proteolytic enzymes (Jacobs et al., 1960). The differences in structure and
organelle location can be observed in Figure 1.4.

14

Figure 1.4
Schematic representation of T. gondii tachyzoites and bradyzoites.
The asexual cycle consists of two life stages; the tachyzoites (left) and the bradyzoites
(right), which differ both structurally and metabolically. Tachyzoites are quickly
replicating while bradyzoites are the slower multiplying, encysted form found during
chronic infection. This image was obtained from Dubey et al., 1998.
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1.5.2.3

Tachyzoite to bradyzoite interconversion

Interconversion between the two developmental stages is often associated with
altered environmental conditions and is typically a factor in pathogenesis. The reversible
process of interconversion between tachyzoites and bradyzoites plays a key role in the
pathogenesis of T. gondii because chronic infection is characterized by the differentiation
of tachyzoites into bradyzoites found in tissue cysts, and recurrence of infection is
characterized by the reconversion of bradyzoites into tachyzoites in immunocompromised individuals (Dubey et al., 1998).

The mechanisms behind the

interconversion process are poorly understood.
There are many limitations in obtaining large amounts of encysted bradyzoites in
vivo, therefore, mimicking the interconversion in vitro allows one to study the process in
detail and gain a better understanding of the mechanisms involved. The stress exerted by
the host’s immune response triggers the formation of bradyzoites, thus a variety of stress
conditions have been applied to culture bradyzoites in vitro. The in vitro cysts have been
shown to be similar to in vivo cysts isolated from brains of chronically infected mice in
that they are both resistant to pepsin treatment (Popiel et al., 1996; Knoll and Boothroyd,
1998).
In order to initiate differentiation in vitro, that is, conversion from tachyzoites to
bradyzoites, a variety of methods can be utilized that exert stress on the intracellular
parasites. These methods include culturing the infected monolayers in the presence of
basic (pH 8.0-8.2) media (Soete et al., 1994; Weiss et al., 1995; Weiss and Kim, 2000),
interferon (IFN)-γ (Bohne et al., 1993), mitochondrial inhibitors (Bohne et al., 1994;
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Tomavo and Boothroyd, 1995), a trisubstituted pyrrole molecule (compound 1) (Radke et
al., 2006) and by increasing the levels of cyclic nucleotides (Kirkman et al., 2001).
The most common method used to initiate in vitro differentiation is to increase the
pH of the culture media to a pH of 8.0-8.2 and culture under ambient CO2, since
bradyzoite formation is most consistent and frequent under this condition (Soete et al.,
1994; Weiss et al., 1995). Alkaline culturing media can result in a direct effect on T.
gondii, as well as an indirect effect from host cells under stress, which subsequently
triggers stage conversion.

The major benefit of using alkaline media is that the

bradyzoites formed have the most defined bradyzoite phenotype that can be achieved in
culture (Radke et al., 2006).
It has been observed that proinflammatory cytokines including interferon-gamma
(IFN-γ) are required for resistance against T. gondii (Suzuki et al., 1988; Bohne et al.,
1993). These cytokines are related to mechanisms involving production of nitric oxide
(NO) and tryptophan starvation, which may lead to a limitation in parasite replication,
thus leading to formation of bradyzoites. Production of nitric oxide in T. gondii is
associated with its ability to react with the iron-sulfur centers present in proteins that are
part of the electron transport chain in aerobic respiration, thus halting the process and
leading to differentiation. Furthermore, sodium nitroprusside (SNP), a nitric oxide donor,
has also been shown to induce bradyzoite formation (Bohne et al., 1994).
Other drugs and chemicals have shown ability to initiate bradyzoite formation in
vitro. In particular, inhibitors of mitochondrial function such as antimycin A (inhibitor of
the electron transport chain), myxothiazol (inhibitor of coenzyme Q-cytochrome c
reductase in the electron transport chain), and oligomycin (inhibitor of mitochondrial
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ATP synthetase function) result in a reduction in growth and formation of bradyzoites
(Bohne et al., 1993, 1994; Soete et al., 1993, 1994).
Nutrient deprivation has also been utilized in differentiation studies. T. gondii
lacks the enzymes required for de novo arginine biosynthesis, thus it requires arginine
from the host cell. Consequently, arginine starvation has shown to lead to bradyzoite
formation. Finally, increasing cyclic nucleotides can also result in differentiation in vitro.
It has been determined that increasing the levels of cyclic GMP (cGMP) and cyclic AMP
(cAMP) leads to differentiation. This is conjunction with using the NO donor sodium
nitroprusside, since this also triggers increased levels of cAMP, and in turn leads to
differentiation (Kirkman et al., 2001). Therefore, using the above mentioned methods, it
is possible to study the differentiation process in vitro to gain a better understanding of
the mechanisms involved.

1.6

Energy production and consumption in Toxoplasma gondii
Intracellular parasites of the Apicomplexa phylum, including Toxoplasma gondii,

rely on eukaryotic host cells for survival. The exclusive replication within host cells
suggests that the metabolism of the host is important for parasite survival and that
parasites have evolved metabolic pathways that reflect their intracellular nature. Thus,
studies of these pathways are important for determining possible targets for drug
development (Kim and Weiss, 2007).
Toxoplasma gondii not only changes its rate of multiplication and morphology
between the tachyzoites and bradyzoites, but it also changes its metabolism upon changes
in environmental conditions. Tachyzoites rely on both aerobic and anaerobic respiration,
whereas bradyzoites rely heavily on anaerobic respiration. As previously noted, certain
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mitochondrial inhibitors such as antimycin A, myxothiazol, and oligomycin result in an
increase in expression of antigens specific to the bradyzoite stage which further suggests
a relation between mitochondrial function and stage conversion (Bohne et al., 1993,
1994; Soete et al., 1993, 1994). Also, some enzymes of the tricarboxylic acid (TCA)
cycle are not present in bradyzoite parasites (Denton et al., 1996), providing further
evidence that mitochondrial oxidative phosphorylation is likely impaired in bradyzoites
and that bradyzoites rely heavily on glycolysis for energy production (Fig. 1.5).
Moreover, interference with the electron transport chain occurs when activated
macrophages produce nitric oxide leading to an increase bradyzoite formation (Bohne et
al., 1994) which further suggests that the host may attempt to remove the parasite by
interfering with the energy generating pathways in order to control proliferation. In order
to compensate, the parasite converts into the slow-replicating, less energy-consuming,
encysted form, thus increasing its viability. Furthermore, T. gondii bradyzoites contain
amylopectin, a polymer of glucose, granules that are not present in high amounts in
tachyzoites, providing energy storage for the encysted and dormant bradyzoites. It has
been suggested that amylopectin granules provide energy for the conversion back into
tachyzoites by the degradation into glucose which provides metabolic substrates and
intermediates for either glycolysis or mitochondrial oxidative phophorylation (Kim and
Weiss, 2007).
Although tachyzoites and bradyzoites have equally functional glycolytic
pathways (Denton et al., 1996), a unique set of glycolytic enzymes are responsible for the
energy production of each differentiation stage (Fleige et al., 2007; Tomavo, 2001). With
the exception of hexokinase and glucose-6-phosphate isomerase, each glycolytic enzyme
is coded by at least two independent genes whose mRNAs are differentially regulated
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(Fleige et al., 2007). It has been shown that three isoenzymes of glycolysis, lactate
dehydrogenase, glucose 6-phosphate isomerase, and enolase, are stage-specifically
expressed in T. gondii (Yang and Parmley, 1997; Dzierszinski et al., 1999).
Since glycolysis is the predominant energy-generating pathway in bradyzoites, the
stage-specific expression of these enzymes suggests that they contain features that are not
available with the tachyzoite isoenzymes.

It is also likely that the isoenzymes are

required for the adaptation of the parasite to differing environments and there may be a
relationship between energy production and stage conversion.
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Figure 1.5
The metabolism of Toxoplasma gondii. Lactate dehydrogenase is shown
as the last committed enzyme of glycolysis in T. gondii. This schematic also
demonstrates the relationship between glycolysis and amylopectin granules. This image
was obtained from Weiss and Kim, 2007.
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1.7

Toxoplasma gondii lactate dehydrogenase
T. gondii contains two isoforms of lactate dehydrogenase (TgLDH1 and TgLDH2,

L-lactate:NAD+ oxidoreductase, EC 1.1.1.27), the last committed enzyme of the
glycolytic pathway (Fig. 1.5). The expression of genes encoding TgLDH1 and TgLDH2
are differentially regulated and commonly used as markers of the differentiation stage:
TgLDH1 is the marker of the tachyzoite stage, while TgLDH2 is that of the bradyzoite
stage (Yang and Parmley, 1997).

Both TgLDH1 and TgLDH2 catalyze the inter-

conversion of pyruvate to lactate and have a preference for the co-enzyme nicotinamide
adenine dinucleotide (NAD+) (Kavanagh et al., 2004).
The mRNA of TgLDH1 has been reported to be present in both the tachyzoite and
bradyzoite stages, however the protein product is only found in tachyzoites, suggesting
that the expression of TgLDH1 may occur at the post-transcriptional or post-translational
level. The TgLDH2 mRNA and protein product, on the other hand, are only present in
bradyzoites, suggesting that the expression is controlled at the transcriptional level.
TgLDH1 and TgLDH2 have 64% nucleotide sequence identity and 71.4% amino acid
sequence identity, with predicted molecular masses of 35,550 and 35,342 Da,
respectively, and predicted isoelectric points of 5.96 and 7.08, respectively (Yang and
Parmley, 1997). As compared to LDH proteins in other apicomplexan parasites, T. gondii
LDH1 and LDH2 share 46.5% and 48.5% amino acid identity with the LDH from
Plasmodium falciparum, respectively (Bzik et al., 1993). Structural and biochemical
analyses showed that the active sites of TgLDH1 and TgLDH2 carry a pentapeptide
insertion (Kavanagh et al., 2004; Bzik et al., 1993), which is similar to the LDH in P.
falciparum and is lacking in the human LDH isoenzyme.

T. gondii LDH2 and P.

falciparum LDH have the same insertion (KSDKE) whereas the insertion differs in
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TgLDH1 (KPDSE) (Yang and Parmley, 1997).

This pentapeptide insertion makes

TgLDH1 and TgLDH2 ideal targets for the development of anti-parasitic agents to
combat both acute and recurrent toxoplasmosis.

By binding to this pentapeptide

insertion, small molecules/ligands would interfere with the activity of TgLDH1 and
TgLDH2. More importantly, the inhibition of TgLDH2 might confer a highly potent antiparasitic effect because the encysted and slow-replicating bradyzoites lack a functional
TCA cycle and respiratory chain (Denton et al., 1996), and would consequently depend
greatly on the activity of TgLDH2 for energy production under anaerobic respiration.
Moreover, previous work showed that the physiological level of TgLDH1 and TgLDH2
expression is required for the parasites to maintain their normal growth and to allow for
differentiation (Al-Anouti et al., 2004). This evidence thus indicates that the activity
along with the temporal regulation of TgLDH1 and TgLDH2 expression could be used as
potential drug targets.

1.8

RNA biochemistry and gene regulation
Posttranscriptional gene silencing (PTGS), or RNA interference (RNAi), is an

evolutionary conserved mechanism wherein RNA plays a role in sequence specific
degradation of mRNA.

It is thought that the native role of RNAi was to inhibit

retrotransposon movement, to silence repeated DNA sequences, and to defend against
viral infection (Mello and Conte, 2004). Today, RNAi has become an important tool for
regulating gene expression and has potential for being a therapeutic technique for the
treatment of infectious diseases and cancers.
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1.8.1

Discovery of RNA interference

RNA induced gene silencing is a novel gene regulatory mechanism that may
either suppress transcription or cause sequence-specific degradation; a process known as
posttranscriptional gene silencing or RNA interference. Initially, PTGS was discovered
in plants, but was quickly followed by a similar discovery in a variety of eukaryotes
including protozoa, nematodes, insects, as well as mouse and human cell lines. The
initial discovery in plants occurred by a search for transgenic petunia flowers that had a
deep purple color after over-expressing chalcone synthase, an enzyme required for
production of anthocyanin pigments. Unexpectedly, the transgenic petunia plants lost
both the endogenous and transgene activity, and the phenomenon was coined
cosuppression (Van Blokland et al., 1994; van der Krol et al., 1990; Napoli et al., 1990).
It was later discovered that introduction of sense and antisense transgenes could initiate
PTGS in plants and other eukaryotes (Francesco et al., 2001).
The discovery of PTGS in plants led to studies in other eukaryotic organisms
where the ability of double stranded RNA (dsRNA) to induce gene silencing in the
nematode Caenorhabditis elegans was demonstrated (Fire et al., 1998). In nematodes,
the unc22 gene is responsible for a myofilament protein that, when present in lowered
amounts, causes a twitching phenotype. Researchers injected the nematode with dsRNA
corresponding to the unc22 gene and observed the twitching phenotype that increased in
the progeny (Fire et al., 1998). These findings paved the way for discoveries of RNA
interference in many eukaryotic organisms, as well as for the discovery of the proteins
involved in the pathway, and most importantly, the use of RNAi to easily create
knockdown mutants.
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1.8.2

General mechanism of an RNA interference pathway

Elucidating the mechanism of RNA interference began with genetic screens of
Neurospora

crassa,

Chlamydomonas

reinhardtii,

Caenorhabditis

elegans,

and

Arabidopsis thaliana to search for mutants defective in RNAi. This led to the discovery
of many essential proteins to the pathway indicated as initiators, effectors, and amplifiers.
The process of RNAi begins with the cleavage of long double stranded RNA into
small interfering RNAs (siRNAs) consisting of 21-25 nucleotides.

Identification in

Drosophila of an enzyme that contains an RNaseIII domain which was known to have
specificity for dsRNA led to the discovery of dicer (Bernstein et al., 2001). Dicer cleaves
dsRNAs into short uniformly sized siRNAs which contain 3’overhangs of 2 to 3
nucleotides and 5’-phosphate and 3’-hydroxyl termini (Elbashir et al., 2001), which is
termed the initiating step. Dicer enzymes consist of four domains including a helicase
domain, RNaseIII domain, dsRNA binding domain, and a PAZ domain. The RNaseIII
domain is responsible for the cleavage action of dicer. The next step is the effector step,
where the siRNAs bind an RNA-induced silencing complex (RISC), which undergoes
activation by ATP exposing the antisense strand of the siRNA, allowing it to identify and
cleave mRNA molecules at 10-11 nt from the 3’ terminus of the guide RNA (Elbashir et
al., 2001) leading to mRNA degradation (Hammond et al., 2000), translational inhibition
(Pillai et al., 2005), or heterochromatin formation (Verdel et al., 2004). The main protein
part of the RISC complex that is responsible for the binding to and cleaving of
homologous mRNA is the argonaute protein, consisting of a PIWI and a PAZ domain
(Hammond et al., 2000).

Therefore, the identification of argonaute in an organism

implies that a mechanism similar to RNAi occurs in the organism. Finally, mutation
studies in Drosophila of an RNA-dependent RNA polymerase (RdRP) protein showed
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that RNAi activity was affected, leading to evidence that this protein plays a role in
amplifying the RNAi signal by generating dsRNA through utilization of the siRNA as
primer molecules (Lipardi et al., 2001; Sijen et al., 2001).
Along with siRNAs, microRNAs have been identified in many organisms such as
D. melanogaster, C. elegans, plants, and humans, and function in RNAi pathways
responsible for preventing mobile transposable elements from disrupting the genomes, as
well as having important roles in development. microRNAs are typically generated from
single stem-loop precursor structures (Hutvágner et al., 2001). Both microRNAs and
siRNAs are processed by dicer proteins; however siRNAs bind the RISC complex,
whereas microRNAs bind other microribonucleoprotein complexes, both of which
contain a member of the PIWI/PAZ family (Fig. 1.5).
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Figure 1.6
Pathways of post-transcriptional gene regulation. The fates of siRNA
derived from antisense transcription, viral infection, and transfection, and miRNA from a
primary mRNA transcript are shown, which result in either mRNA cleavage or
translational inhibition. This image was obtained from Filipowicz et al., 2005.
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1.8.3

Argonaute family of proteins

An important core component of the RISC complex has been identified as an
argonaute protein that is responsible for the cleavage of mRNA transcripts guided by
siRNAs (Song et al., 2004; Liu et al., 2004). Argonaute proteins consist of two structural
domains: a central PAZ domain and a C-terminal PIWI domain, where the PAZ domain
binds siRNA and the PIWI domain cleaves mRNA. Structural studies of argonaute from
Pyrococcus furiosus indicated similarities between the PIWI domain and the RNase-H
family of ribonucleases providing further evidence that argonaute is responsible for
cleavage (Song et al., 2004).
Along with functions in RNAi, argonaute proteins have also been shown to
function in developmental processes of many organisms (Carmell et al., 2002; Jaronczyk
et al., 2005). Studies in Drosophila and C. elegans of reduced expression of argonaute
resulted in defective germlines leading to speculation that there are evolutionarily
conserved roles in germline stem cell maintenance (Cox et al., 2000; Tijsterman et al.,
2002).
Studies of the role of argonaute in Trypanosoma brucei has suggested that
protozoans contain an RNAi pathway that resembles that of multi-cellular eukaryotic
organisms (Ullu et al., 2004). The T. brucei genome contains two argonaute genes,
TbAgo1 and TbPiwi, where only TbAgo1 functions in RNAi (Durand-Dubief and Bastin,
2003). Further studies on TbAgo1 determined that it is involved in controlling siRNA
and retrotransposon transcript levels, as well as having a role in chromosome segregation
and mitotic spindle assembly (Shi et al., 2004; Durand-Dubief and Bastin, 2003).
Searching genomic databases has identified both dicer and argonaute homologs in
other protozoans. Specifically, Toxoplasma gondii argonaute (TgAgo) has recently been
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identified. It was found that TgAgo is a 58 kDa protein containing a conserved PIWI
domain, and a non-conserved PAZ domain (Fig. 1.6), that participates in double stranded
induced gene silencing in T. gondii (Al Riyahi et al., 2006). However, TgAgo’s role in
either an RNA interference pathway or in other cellular pathways is still unknown.
Therefore, further studies are required to elucidate the role of argonaute in T. gondii.
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Figure 1.7
Alignment of Toxoplasma gondii argonaute. Alignments of structural
domains of T. gondii argonaute protein (TgAgo) with that of: Arabidopsis thaliana
argonaute 1 (AtAgo1, accession number: U91995), Homo sapiens argonaute 2/EIF2C2
(HsAgo2, accession number: NP_036286), Trypanosoma brucei argonaute 1 (TbAgo1,
accession number: AAR10810), and Archaeoglobus fulgidus Piwi protein (AfPiwi, PDB
ID: 1W9H). The domain locations and sizes are estimated and solid lines indicate amino
acid sequences with no recognized domains. This image was obtained from Al Riyahi et
al., 2006.
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1.9
I.

Objectives
The current studies aimed to elucidate the role of the glycolytic enzyme lactate

dehydrogenase (TgLDH) within the differentiation process.

To do so, transgenic

parasites over-expressing either TgLDH1 or TgLDH2 were generated.

Phenotypical

analyses were conducted to measure changes in growth under tachyzoite and bradyzoite
conditions, overall TgLDH enzymatic activity, and differentiation ability to determine if
over-expression of TgLDH’s affected any of the above process.
II. It was of interest to study if argonaute (TgAgo) played a role in differentiation. A
fusion between TgAgo and a cherry fluorescent protein was generated and over-expressed
in T. gondii. The differentiation ability of this strain was compared to that of a parental
strain and a TgAgo knockout strain.
III. The relationship between TgAgo and a possible gene silencing pathway of T. gondii
was studied. The transgenic parasites containing altered expression of TgAgo were tested
in ability to perform double stranded induced gene silencing, and as well, the expression
of putative dicer proteins was monitored upon alterations in TgAgo expression.
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Chapter II
Materials and Methods

2.1

Plasmid design and constructs
2.1.1 Construction of pTUB8Myc_His_TgLDH
The coding sequences of TgLDH1 and TgLDH2 (GenBank accession nos.

U35118 and U23207) were amplified from pMAL_LDH1 and pMAL_LDH2 (plasmids
obtained from Dr. S. Parmley, Palo Alto Medical Foundation) using oligonucletide
primers,

5'LDHxNsiI:

GATTTCAGAATTCGGATCC

and

3'LDHxPacI:

CCCTTAATTAAGTGCCAAGCTTAAGATC to generate PCR products with NsiI on
their 5'-terminus and PacI on their 3'-terminus. The PCR products were subsequently
cloned into the Toxoplasma-expression plasmid, pTUB8Myc_His_X-HX (gift from Dr.
D. Soldati, University of Geneva), so that the expression of TgLDH1 or TgLDH2 was
under the control of a modified tubulin (TUB) promoter and the recombinant proteins
were led by Myc- and His-epitope tags on their N-terminus to give ~39 kDa and ~40 kDa
protein products, respectively. The constructs were analyzed by restriction endonucleases
and confirmed by nucleotide sequencing reactions.
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2.1.2 Construction of pTUB8_TgAgo_ChFP plasmid
The open reading frame of TgAgo (GenBank accession no. DQ196314) was PCR
amplified

using

the

oligonucleotide

primers

AAAGCTAGCAAAATGATCATGCCTCCCCGAAATCG

Nhe1on5TgAgo:

and

Bgl2on3TgAgo:

AAAAGATCTACAG AACACCATCGGGGTC to generate a fragment with NheI on the
5’ terminus and BglII on the 3’ terminus. The fragment was cloned into a BlueScript pkS
plasmid (Strategene) for blue/white screening, and the correct plasmid was confirmed by
restriction digestion using XhoI and PvuII. The TgAgo coding sequence was obtained by
digestion with NheI and BglII and was further cloned into the Toxoplasma-expression
plasmid, pTub8_ChFP (Dr. John Murray, University of Pennsylvania), and verified using
restriction digestion analysis and DNA sequencing. The expression of TgAgo, fused to a
cherry fluorescent protein on the C-terminal, was under the control of a modified TUB
promoter producing a protein product of ~85 kDa.

2.2

General molecular biological techniques for plasmid generation
2.2.1 Transformation of Top10 Escherichia coli cells
General molecular biological techniques were used for the transformation of E.

coli cells, isolation of plasmid DNA, and restriction digestions of plasmids for
confirmation of constructs. Briefly, all plasmids were transformed into Top10 E. coli
subcloning-grade competent cells by the heat shock method.

Competent cells were

incubated with plasmid DNA on ice for 20 min, followed by heat pulsing at 42oC for 45 s,
and incubating on ice for another 2 min. Next, 400 µL of pre-heated Luria-Burtani (LB)
medium (10 g/L tryptone, 5 g/L bacto-yeast extract, 10 g/L NaCl) was added, and the
reaction was incubated for 30 min at 37oC with agitation. The cells were then plated on
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an LB agar plate with the appropriate antibiotic (10 g/L tryptone, 5 g/L bacto-yeast
extract, 10 g/L NaCl, 15 g/L agar, 1mg/L antibiotic) and grown at 37oC overnight.

2.2.2 Plasmid isolation by minipreps
Plasmids were isolated by growing a bacterial colony in 3 mL of LB broth
supplemented with antibiotic at 37oC overnight with agitation. Half of the culture was
centrifuged at 12,000 rpm for 1 min and the pellet was resuspended in 100 µL of 25mM
Tris-HCl (pH 8.0), 10 mM EDTA, 200 µL of 0.2N NaOH, and 1% SDS. Furthermore,
150 µL of 3 M NaOAc (pH 5.2) was added, the sample was mixed by inversion, and
centrifuged at 12,000 rpm for 15 min. The clear supernatant was combined with 400 µL
of TE-buffered phenol:chloroform:isoamyl alcohol (25:24:1), vortexed for 30 s, and
centrifuged at 12,000 rpm for 5 min at room temperature. The plasmid DNA was
precipitated with 800 µL of 95% ethanol and centrifuged at 12,000 rpm for 15 min at 4oC.
The pellet was washed with 75% ethanol, air dried, resuspended in 30 µL of TE buffer
containing 20 µg/ml RNase A and incubated at 37oC for 15 min.

2.2.3

Restriction digestion

Plasmids were digested with the appropriate restriction enzymes for a minimum of
4 h at 37oC. The fragments were visualized on 1% (w/v) agarose gels (0.4 g agarose in 40
mL of 1X TAE buffer, and 0.02% (w/v) ethidium bromide). The samples were mixed
with gel loading buffer (6x: 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene cyanol
FF, and 40% (w/v) sucrose in water) and the gel was electrophoresed for 30 min at 130 V
in the Miniature Horizontal Gel System MLB-06 (Tyler Research Instruments) with 1X
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TAE buffer. The gel was visualized and imaged using the Alphaimager Imaging System
with AlphaEase software.

2.3

Parasite cultures
Human foreskin fibroblasts (HFF) and the laboratory strains, RH and RHΔHX,

which are type I strains of T. gondii, were obtained from National Institutes of Health
AIDS Research and Reference Reagent Program. HFF cells were grown in Dulbecco's
Modified Eagle Medium (DMEM) (Invitrogen) supplemented with 10% cosmic calf
serum (Hyclone) and antibiotic-antimycotic (Invitrogen) and used for T. gondii infection.
The infected HFF monolayers were maintained using Minimum Essential Medium
(MEM) (Invitrogen) supplemented with 1% dialyzed calf serum (Hyclone) and antibioticantimycotic. The RHΔHX parasite strain was chosen because of the ability to generate
transgenic parasites using hypoxanthine-xanthine-guanine phosphoribosyltransferase as a
selectable marker (Donald et al., 1996). Using a previously described method (Roos et
al., 1994), transgenic parasites were generated by electroporation of RHΔHX with
plasmids containing HXGPRT and selected and maintained in the culture media
containing 25 µg/ml mycophenolic acid and 50 µg/ml xanthine. RH parasites were
electroporated with plasmids containing chloramphenicol acetyltransferase (CAT) as a
selectable marker and maintained in media containing 20 µM chloramphenicol. Freshly
released parasites were subcultured every few days until further needed.

2.4

Transfection of Toxoplasma gondii by electroporation
Freshly lysed parasites were centrifuged at 1,500 rpm for 15 min and the pellet

was resuspended in 400 µL electroporation buffer (120 mM KCl, 0.15 mM CaCl2, 10 mM
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K2HPO4/KH2PO4 (pH 7.6), 2 mM EDTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione).
10 µg of plasmid DNA was added in 4 mm electroporation cuvettes and pulsed at a
voltage of 1,500 V, resistance of 25 Ω, and a capacitance of 25 µF using the BTX model
600 Electro Cell Manipulator (Genetronics). The parasites were then added to a confluent
plate of HFF cells after a 15 min incubation period, and grown for 24 h followed by
addition of the appropriate selection.

2.5

Isolation of genomic DNA
Genomic DNA was isolated using the DNAzol Reagent (Invitrogen) according to

the manufacturer’s instructions. Briefly, parasite pellets were resuspended in 500 µL of
DNAzol Reagent and lysed by gentle pipetting, followed by centrifugation for 10 min at
10,000 rpm at room temperature, and the viscous supernatant was transferred to a fresh
tube. The DNA was precipitated by the addition of 250 µL of 100% ethanol, mixing by
inversion, and storing at room temperature for 3 min, followed by centrifugation at 4,000
rpm for 2 min at room temperature to pellet the DNA. The DNA precipitate was washed
twice with 800 µL of 75% ethanol, air dried for 15 s, and resuspended in 200 µL of 8 mM
NaOH and 32 µL of 0.1 M HEPES.

2.6

Genotyping of Toxoplasma gondii
Isolated genomic DNA was subject to amplification by PCR using the primers

specific to GRA6 and SAG2; GRA6-F1: TTTCCGAGCAGGTGACCT and GRA6-R1x:
TCGCCGAAGAGTTGACATAG and SAG2.F2: ATTCTCATGCCTCCGCTTC and
SAG2.R: AACGTTTCACGAAGGCACAC. The PCR reaction consisted of 25 cycles of
denaturing at 94oC for 15 s, annealing at 55oC for 15 s, and extension at 72oC for 45 s,
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with a final extension at 72oC for 5 min. PCR products were digested with MseI and
HhaI for GRA6 and SAG2, respectively, and visualized on a polyacrylamide gel (4.8 mL
30% acrylamide, 4.8 mL H20, 2.4 mL 5X tris-borate EDTA (TBE)), where TBE is 54 g/L
Tris base, 27.5 g/L boric acid, 20 mL/L of 0.5 M EDTA, (pH 8.0).

2.7

Lactate dehydrogenase enzymatic activity assay
Enzymatic assays were performed as previously described (Al-Anouti et al., 2004;

Dando et al., 2001; Kavanagh et al., 2004). Briefly, freshly released tachyzoites were
harvested and lysed in 100 mM Tris (pH 7.4) and 0.5 mM PMSF protease inhibitor.
Protein concentrations were determined using the Bradford reagent (BioRad Laboratories,
Inc.). Reactions were carried out at 25°C in a reaction buffer containing 100 mM Tris
(pH 7.4), 0.1 mg/ml NADH (Sigma-Aldrich), and 5 µg of cell-free lysates. Reactions
were initiated by the addition of 1.6 mM pyruvate (Sigma-Aldrich) and monitored at 340
nm for the change in absorbance of NADH (∈ = 6220 M-1cm-1). The assays were
performed in triplicate, and average values were presented with their standard deviations.

2.8

Production of double stranded RNA
T7 promoter sites were incorporated into either side of the UPRT gene using the

primers T7AntisenseUP: TAATACGACTCACTATAGGGTTCCAAAGTACCGGT and
T7promoterGG: TAATACGACTCATATAGG. The PCR reaction consisted of 30 cycles
of denaturing at 94oC for 30 s, annealing at 55oC for 30 s, and extension at 72oC for 2 min
30 s, with a final extension at 72oC for 5 min. The PCR template was then subjected to
an in vitro transcription reaction (200 u of T7 polymerase, 2.5 mM rNTPs, 50 u Murine
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RNase inhibitor, 10 mM DTT, 1/100 dilution pyrophosphatase) for 4 h at 37oC. The
reaction was quenched with 2 u RQ1 RNase-Free DNase (Promega Corp.) for 15 min at
37oC. The sample, visualized on a 1% agarose gel, was subjected to phenol:chloroform
precipitation, and quantified by spectrophotometry (Genesys 10uv Thermo Electron
Corporation) by measuring absorbance at 260 nm and 280 nm.

2.9

RNA interference assay
Electroporation was used to introduce dsRNA corresponding to UPRT into

parasites which were then infected onto HFF cells grown in a 24-well plate, and allowed
to grow for 24 h. The media was replaced with appropriate selection media, and 1 µCi of
3
1H

Uracil was added to each well. HFF cells with only electroporation buffer and no

parasites were used as a control. After incubation at 37oC for another 4 h, the plate was
chilled at -20oC for 2 min, followed by addition of 1 mL of 0.6 M trichloroacetic acid
(TCA) to the existing media. The monolayer was fixed for at least 1 h at 4oC. The wells
were washed repeatedly for approximately 4 h with ddH2O and gentle agitation.
Scintillation counting was performed on each wash sample containing 250 µL of sample
and 3 mL of scintillation fluid. Once wash readings were approximately 50-300 cpm, the
ddH2O was replaced with 0.5 mL of 0.1 N NaOH and incubated for 1 h at 37oC.
Scintillation counting was performed on 250 µL of each sample with 3 mL of scintillation
fluid.

2.10

Antibodies
The rabbit anti-red fluorescence protein (RFP) antibody was obtained from

Biovision (Mountain View, CA). The mouse anti-Myc antibody (9E10) and the mouse
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anti-Tub (12G10) antibodies were developed by J. Michael Bishop, and Joseph Frankel
and E. Marlo Nelsen, respectively, and obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the NICHD and maintained by The
University of Iowa (Iowa City, IA).

The rabbit anti-LDH1 and rabbit anti-LDH2

antibodies were obtained from Dr. Stephen Parmley (Palo Alto Medical Foundation).
The rabbit anti-RNaseIII antibody was produced using a peptide derived from the Nterminal of the signature domain of an RNaseIII domain and obtained from ProSci
Incorporated (Poway, CA). The rabbit anti-Bag1 antibody was obtained from Dr. Louis
Weiss. Horseradish peroxidase-conjugated goat anti-mouse and horseradish peroxidaseconjugated goat anti-rabbit were purchased from Rockland (Gilbertsville, PA).
Rhodamine-conjugated sheep anti-mouse was purchased from Rockland (Gilbertsville,
PA). Finally, FITC-conjugated Dolichos biflorus agglutinin was obtained from SigmaAldrich.

2.11

Growth assays and immunofluorescence assays
To monitor the tachyzoite growth, the parasites were infected onto HFF

monolayers grown on coverslips and kept under 37°C and 5% CO2 for 24 and 48 hours
(Al-Anouti et al., 2004). To induce stage conversion and measure bradyzoite growth, the
infected monolayers were grown under atmospheric CO2 and in RMPI-1640 media
(Sigma-Aldrich) supplemented with 50 mM HEPES (pH 8.2), 5% dialyzed serum, and
antibiotic-antimycotic for 5 days (Soete et al., 1993, Tomavo, 2001). After 5 days, the
alkaline stress was removed and parasites were grown under tachyzoite conditions for
another 48 h to measure the interconversion ability.
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Immunofluorescence assays were performed by fixing the infected monolayers
grown on coverslips with 3% paraformaldehyde. The nuclei of intracellular parasites and
host cells were visualized by staining with 100 µM Hoechst (Sigma-Aldrich). FITCconjugated Dolichos biflorus agglutinin (1:300) was used for the visualization of cyst
structures. The parasites, from an average of 100 vacuoles or cysts per coverslip, were
counted in triplicate to determine the number of parasites per vacuole or cyst.
For other immunofluorescence assays, the paraformaldehyde fixed monolayers
were permeabilized with 0.25% Triton X-100 in PBS, and non-specific sites were blocked
using 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS.

The slides were

incubated with the primary antibodies: mouse anti-Myc (1:500), rabbit anti-TgLDH1
(1:1,000) or rabbit anti-TgLDH2 (1:1,000). Coverslips were then washed 3 times for 5
min each in PBS and incubated with the secondary antibodies: rhodamine-conjugated
sheep anti-mouse (1:800) or rhodamine-conjugated goat anti-rabbit (1:800). All images
were taken with a Q-imaging CCD camera on a Leica DMIRB microscope using the
Northern Eclipse software.

2.12

Immunodectection
Western blot analyses were performed using the lysates prepared from freshly

lysed

parasites

in

100

mM

Tris-HCl

(pH

7.6)

containing

0.5

mM

phenylmethylsulfonylfluoride (PMSF) protease inhibitor (Al-Anouti et al., 2004).
Briefly, cell pellets were resuspended in PBS, sonicated, and centrifuged at 13,000 rpm
for 15 min at 4oC. The supernatant was separated from the cellular debris. Protein
concentration was measured using the Bradford reagent according to manufacturer’s
40

instructions. Cell lysates were denatured in 5X SDS protein loading dye, resolved on a
12% SDS-PAGE at 120 V for 1 h in a 1X SDS-PAGE running buffer (25 mM Tris-base
(pH 8.3), 250 mM glycine, and 0.1% SDS) using the vertical gel electrophoresis system
from BRL (Bethesday Research Laboratories), and transferred to a nitrocellulose
membrane (Pall Corporation) at 80 V for 1.5 h in transfer buffer (20% methanol, 39 mM
glycine, 48 mM Tris-base, 0.037% SDS, (pH 8.3)). Following the transfer, blots were
blocked in 5% non-fat milk in 1X Tris-buffered saline containing Tween®-20 (TBST;
0.068 M NaCl, 8.3 mM Tris-base (pH 7.6), 0.1% Tween) for 1 h at room temperature.
Membranes were then probed with the specific primary antibodies in 2% non-fat milk in
TBST for 1 h at room temperature. The primary antibodies used were: mouse anti-Myc
(1:1,000), mouse anti-Tub (1:1,000), rabbit anti-LDH1 (1:2,000), rabbit anti-LDH2
(1:2,000), rabbit anti-Bag1 (1:250), rabbit anti-RFP (1:250), and rabbit anti-RNaseIII
(1:4,000).

The blots were washed 3 times for 5 min, incubated in the appropriate

secondary antibody for 45 min at room temperature, and washed again 3 times for 5 min
each. The secondary antibodies used were: horseradish peroxidase-conjugated goat antimouse (1:10,000) and horseradish peroxidase-conjugated goat anti-rabbit (1:20,000).
Chemiluminescent detection was performed using the chemiluminescent HRP substrate
kit (Millipore).

2.13

Immunoprecipitation assays
In order to immunoprecipitate putative dicer proteins or TgAgo_ChFP, rabbit anti-

RNaseIII and rabbit anti-RFP were used, respectively. Protein-A agarose beads (10 µL
beads/500 µL reaction) were incubated with the primary antibody on a rotator for 1 h at
room temperature. The beads were collected by centrifugation at 4,000 rpm for 30 s and
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the supernatant removed. The appropriate parasites were lysed in either polysome lysis
buffer (100 mM KCl, 5 mM MgCl2, 10 mM HEPES, 0.5% Nonidet P40, 1 mM DTT, 2
mM vanadyl ribonuclease, 10 % SDS) for dicer immunoprecipitation, or a Tris buffer (50
mM Tris-HCl, (pH 7.6), 1% Triton X-100, 150 mM NaCl, 0.1% SDS) for TgAgo_ChFP
immunoprecipitation and incubated with the antibody bound beads for 4 h at 4oC while
rotating. The beads were washed 3 times for 5 min at 4oC with wash buffers, (100 mM
KCl, 5 mM MgCl2, 10 mM HEPES, 0.5% Nonidet P40, 1 mM DTT, 2 mM vanadyl
ribonuclease, 10 % SDS, 100 mM NaCl) and (50 mM Tris-HCl, (pH 7.6), 0.1% Triton X100, 150 mM NaCl, 0.1% SDS) for dicer and TgAgo_ChFP, respectively. The bound
proteins were eluted by addition of 30 µL SDS-loading dye and boiled for 5 min. The
samples were analyzed by western blot analysis and coomassie staining.

2.14

Mass spectrometry
The sample was lysed, electrophoresed by SDS-PAGE, and immunoblotted onto a

PVDF membrane as previously described. The lane was cut into three sections and
western blot analysis was performed on the two outer sections using rabbit anti-RFP
(1:250) and horseradish peroxidase conjugated goat anti-rabbit (1:20,000). The bands
were visualized using 3 mg of the colorimetric substrate DAB (3,3'-diaminobenzidine) in
20 mL of 0.05 M Tris-HCl (pH 7.2), and 20 µL of 3% H2O2, and matched to the unused
section. The band with the corresponding size was excised using a sterile blade in a
laminar flow hood. The band was washed 3 times each with methanol and ddH2O, and
blocked with 1 mL of 0.5% polyvinylpyrrolidine-360 (Sigma) containing 100 mM acetic
acid for 30 min at 37oC, followed by 5 washes with ddH2O. Tryptic digestion was
performed with 260 ng of sequencing grade trypsin (Promega Corp.) resuspended in 50
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mM ammonium bicarbonate (pH 8.0) to a final concentration of 13ng/µL, at 37oC
overnight with agitation. The reaction was quenched by addition of formic acid at a final
concentration of 1%. Additional peptides were released by sonicating the membrane for
3 min in 300 µL of ddH2O and the solution was concentrated to approximately 10 µL by
speed vacuuming. The tryptic peptides were analyzed by mass spectrometry using a
matrix-assisted laser desorption ionization (MALDI)-time of flight (TOF) mass
spectrometer (Applied BioSystems Voyager-DE™ PRO BioSpectrometry™ Workstation;
Applied BioSystems, Framingham, MA). The peptides were crystallized on a MALDI
target plate (Applied BioSystems) using an α–cyano-4-hydroxycinnamic acid matrix
(Sigma-Aldrich, Inc.) in 60% acetonitrile, 1% formic acid.

The tryptic peptide ion

masses were compared to those generated by an in silico tryptic digestion of the
TgAgo_ChFP protein using the MS-Digest program of Protein Prospector (UCSF;
University of California, San Francisco, CA).
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Chapter III
Results

This chapter is divided into two parts. Part I focuses on the role of the lactate
dehydrogenase enzyme of T. gondii in the process of interconversion.

Transgenic

parasites were generated by over-expressing either TgLDH1 or TgLDH2 in tachyzoites
and the phenotypes were monitored when the parasites were grown in the presence of
alkaline stress. Part II focuses on the argonaute protein of T. gondii, and its role in
interconversion and post-transcriptional gene regulation. The studies were aimed at
determining the differentiation and gene knockdown abilities of a knockout strain of
TgAgo and a transgenic strain over-expressing TgAgo.

PART

I:

Physiological

characterization

of

Toxoplasma

gondii’s

lactate

dehydrogenases

3.1

Genotyping of Toxoplasma gondii strains
When compared to type II strains of Toxoplasma gondii, type I strains have been

shown to be a more virulent, lethal type of parasite, which show a minimal ability to
differentiate into bradyzoites in vitro (Sibley and Boothroyd, 1992). To ensure that the
parental RH and RHΔHX strains used in these studies were type I strains, and were not
contaminated with any type II strains, genotyping reactions were performed. In order to
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genotype the T. gondii strains as type I or type II, restriction fragment length
polymorphisms (RFLP) of PCR amplified gene products were used. The genes encoding
SAG2 and GRA6 have been identified by Howe et al. (1997) and Fazaeli et al. (2000),
respectively, to contain several polymorphisms that allow for genomic typing between the
three types. The oligonucleotide primers used for PCR amplification were designed by
Khan et al. (2005). 200 bp of the 3’ terminus of SAG2 was amplified and digested with
HhaI. Type I does not contain the restriction site and therefore the product is the same
size as the PCR fragment. On the other hand, type II parasites contain the HhaI digestion
site in the PCR amplified region, thus 2 fragments are produced from the digestion (Fig.
3.1A). The GRA6 gene was PCR amplified to produce a fragment of 346 bp, which was
then digested with MseI. Type I parasites contain the MseI site close to the 3’ end
generating 2 fragments of 261 bp and 85 bp. Type II parasites, on the other hand, contain
the MseI site in the middle of the fragment generating 2 products of 162 bp and 182 bp
(Fig. 3.1B). Only patterns specific to type I were detected, thus confirming that the
parental strains used were of type I origin and were not contaminated with any type II
parasites.
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A

B

Figure 3.1
Genotyping of two laboratory strains of Toxoplasma gondii, RH and
RHΔHX. (A) SAG2 and (B) GRA6 primers were used to generate PCR products which
were then digested with HhaI and MseI, respectively. The undigested and digested
samples were resolved on a 12% polyacrylamide gel.
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3.2

Over-expressing recombinant TgLDHs in Toxoplasma gondii
To study the effect of TgLDH1 and TgLDH2 on differentiation, clonal parasites

that stably over-expressed either TgLDH1 or TgLDH2 were generated. Those selected
for the study were named RML1-A & -B and RML2-A to -D, respectively where R
indicates the RHΔHX parental strain, M indicates the Myc tag, and L1 and L2 indicate
over-expressed TgLDH1 and TgLDH2, respectively.
To determine levels of recombinant TgLDH1 and TgLDH2 expression in the
tachyzoite stage, western blot analysis was employed.

Figure 3.2A indicated that

tachyzoites of the parental parasite (RHΔHX) strain expressed detectable levels of
TgLDH1, but not TgLDH2, which is in agreement with previous observations (Yang and
Parmley, 1995, 1997). Endogenous TgLDH1 has a molecular weight of ~35 kDa, and
was detected in all samples prepared from the selected clones as well as in the RHΔHX
strain, using an anti-TgLDH1 antibody.

In the RML1-A and RML1-B strains,

recombinant TgLDH1 protein was detected by both anti-Myc and anti-TgLDH1
antibodies, which resolved at ~39 kDa. As expected, recombinant TgLDH2 (~40 kDa)
was only detected in the four clonal RML2 (A to D) strains using anti-TgLDH2 and antiMyc antibodies, while no endogenous levels of TgLDH2 were detected in any of the
strains, since tachyzoites do not express TgLDH2 (Fig. 3.2A).
To normalize the expression of the recombinant proteins in the transgenic clonal
parasites, the expression levels, as detected by anti-TgLDH1 or anti-TgLDH2, were
quantified against those of the internal control, tubulin (Fig. 3.2B). Between the clonal
TgLDH1 strains, RML1-A exhibited a higher level of recombinant TgLDH1 than RML1B.

Among the clonal TgLDH2 strains, RML2-C exhibited the lowest amount of

recombinant TgLDH2 and RML2-A and RML2-D had the highest levels. It was noted
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A

B

Figure 3.2
Expression of the recombinant proteins in the selected clones.
(A)Western blot analyses of recombinant Toxoplasma gondii lactate dehydrogenase
(TgLDH1 and TgLDH2) expression. Anti-Myc, -TgLDH1, -TgLDH2 and -Tub
antibodies were used in revealing the corresponding proteins as indicated on the left.
Estimated sizes of the detected bands are indicated on the right. (B) Comparative levels of
the recombinant TgLDH proteins among the clonal strains was obtained following
densitometric measurements of the band intensities and normalized against those of
tubulin (Tub).
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that there was no direct relationship between the level of recombinant protein expression
and the endogenous level of TgLDH1 expression.
Prior to phenotypical analyses, immunofluorescence assays were performed to
ensure that recombinant TgLDH1 and TgLDH2 proteins were expressed uniformly in
each clone (Fig. 3.3). The expression of recombinant proteins was uniform in all strains
as detected by an anti-Myc primary antibody and a rhodamine-conjugated anti-mouse
secondary antibody. Figure 3.3 shows the recombinant protein in the RML1-B strain.
The results were similar for all other clones. It was observed that recombinant TgLDH1
and TgLDH2 proteins localized to the cytosol, which is in agreement with previous
studies (Ferguson et al., 2002).
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Figure 3.3 Expression of TgLDH1 in tachyzoites. Immunofluorescence detection
of Myc-tagged Toxoplasma gondii lactate dehydrogenase 1 (TgLDH1) in the tachyzoites
of RML1-B. Nuclei of the HFF host and the tachyzoites were stained with Hoechst, as
indicated by an arrowhead and an arrow, respectively. The scale represents 20 microns.
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3.3

Effect of TgLDH1 or TgLDH2 over-expression on overall enzymatic activity
of TgLDH
To determine if the varied levels of over-expression altered the overall activity of

TgLDH, an LDH enzymatic assay was performed by measuring the change in NADH
absorbance at 340 nm when pyruvate was added to freshly lysed parasites (Table 3.1).
The overall TgLDH activity of the parental tachyzoites, RHΔHX, was found to be 1473 ±
4 nmol. min-1.mg-1. The over-expression of TgLDH1 in the RML1-A and RML1-B
strains displayed similar activity as parental, 1428 ± 107 and 1933 ± 241 nmol. min-1.mg1

, respectively. The RML2-A, RML2-B, RML2-C, and RML2-D strains with over-

expressed TgLDH2, with activities of 1260 ± 287, 1072 ± 210, 1009 ± 185, and 1167 ±
132 nmol. min-1.mg-1, respectively, also resembled the activity of the parental strain.
Therefore, varied levels of over-expression did not decrease nor increase the overall
enzymatic activity of TgLDH.
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Strains

Activities (nmol.min-1.mg-1)

RHΔHX

1473 ± 4

RML1-A

1428 ± 107

RML1-B

1933 ± 241

RML2-A

1260 ± 287

RML2-B

1072 ± 210

RML2-C

1009 ± 185

RML2-D

1167 ± 132

Table 3.1
Overall enzymatic activity of TgLDH in transgenic and parental
strains. Enzymatic activity of parental and transgenic clones was monitored by the
change in absorbance of NADH at 340 nm. The values and standard deviations are given
in nmol.min-1.mg-1.
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3.4

Phenotypical analyses of transgenic parasites over-expressing TgLDH1 and
TgLDH2
Clonal RML1-B, RML2-A, and RML2-D strains were selected for further

phenotypical analyses since there was no apparent correlation between the levels of overexpression, localization and the overall TgLDH activity.
3.4.1

Growth of transgenic parasites under tachyzoite conditions

Growth of tachyzoites was monitored to determine if over-expression of TgLDH
caused any changes to occur. Growth assays were conducted using clonal parasites from
early and late passages, where the former were from less than three passages and the latter
from six passages, to ensure that the results were consistent, since it has previously been
reported that serial passages of transgenic T. gondii cultures may cause a reduction in the
expression of recombinant proteins (Van et al., 2007).
The parasites were infected under tachyzoite conditions, and the number of
parasites in the vacuoles was monitored from the early (Fig. 3.4 A and B) and late
passages (Fig. 3.4 C and D) after 24 and 48 hours. The infected monolayers were fixed
after 24 or 48 hours and stained with Hoechst to facilitate counting. At 24 hours postinfection, 50% of vacuoles formed by all strains, including RML1-B, RML2-A, RML2-D,
and RHΔHX, contained 8 parasites. At 48 hours post-infection, all strains showed a
similar growth pattern of having about 50% of vacuoles with more than 32 parasites, and
the early and late passages exhibited the same trend. Therefore, the over-expression of
recombinant TgLDH1 or TgLDH2 proteins had minimal effect on the growth of
tachyzoites, as compared to the parental strain, under tested conditions.
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A

B
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C

D

Figure 3.4
Tachyzoites’ growth analyses. Comparative growth analysis of parasites
from an early passage (A and B) and late passage (C and D) is displayed as the fraction
(%) of vacuoles containing 2, 4, 8, 16, or >32 parasites. An average of 100 vacuoles were
counted from each strain at 24 (A and C) or 48 (B and D) hours post-infection, in
triplicate.
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3.4.2

Differentiation of transgenic parasites using alkaline media

The expression of TgLDH1 and TgLDH2 proteins has been widely used as a
marker of parasite differentiation (Weiss and Kim, 2000; Yang and Parmley, 1997), and
previous studies have shown that knockdown of TgLDHs caused a decrease in
differentiation ability (Al-Anouti et al., 2004). Thus, it was important to investigate
whether TgLDH1 or TgLDH2 over-expression also affected the parasite’s ability to
differentiate into bradyzoites.
Parasites were infected onto HFF cells, and the monolayers were cultured under
alkaline conditions (pH 8.2) for 5 days, which has been shown to cause differentiation
(Boothroyd et al., 1997; Soete et al., 1993). To ensure that the cyst structure formation
correlated with the presence of bradyzoite markers, western blot analysis was performed.
Parasites cultured under alkaline conditions were compared to those cultured under
tachyzoite conditions for the presence of the bradyzoite-specific antigen 1 (BAG1, 30
kDa) using the anti-BAG1 antibody (Fig. 3.5; Bohne et al., 1995). A mixed population
strain of TgLDH2 over-expressed parasites, RML2-mix, was used as a test in western blot
analysis, while PLKΔHX, a type II parasite known to readily differentiate, was used as a
positive control. Figure 3.5 shows that BAG1 is detected in the lysate of the bradyzoite
strains of both RML2-mix and PLKΔHX, while it is not detected in the lysate of the
tachyzoite samples, further confirming that differentiation did occur and can be correlated
with cyst wall formation that appears in parasites cultured for 5 days in alkaline media.
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Figure 3.5
Expression of the bradyzoite marker BAG1. Western blot analysis of
Toxoplasma gondii tachyzoites (tz) and bradyzoites (bz) of a type II strain, PLKHX, and a
transgenic line over-expressing TgLDH2, RML2-mix. Anti-BAG1 was used to reveal the
BAG1 protein at 30 kDa in the bradyzoite samples only. Tubulin was used as a loading
control.
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To determine if cyst formation occurred in the transgenic clones, levels of
recombinant proteins in the clonal parasites were evaluated using an anti-Myc primary
antibody and a rhodamine-conjugated sheep anti-mouse secondary antibody; while cyst
wall formation was detected using FITC-conjugated Dolichos lectin. Figure 3.6 indicates
that a detectable cyst wall was observed in the RML2-A strain, which was similar to all
other transgenic strains, and that recombinant protein expression correlated with the cyst
wall. The formation of cysts was counted in all strains and quantified against the total
number of vacuoles. It was observed that the parental RHΔHX strain could differentiate,
with ~14% of vacuoles forming cyst structures under conditions tested. Notably, all
clonal strains, including RML1-B, RML2A and RML2-D, showed an enhanced ability to
differentiate and form cyst structures. From all transgenic parasite clones counted, over
half of the vacuoles exhibited distinctive cyst structures, demonstrating that TgLDH overexpression caused an increase from ~14% (parental) to ~60% (transgenic) in cyst
formation (Fig. 3.7). To ensure that differentiation and cyst formation was not an artifact
derived from the expression of a recombinant protein, an unrelated protein, Myc-tagged
GFP, was over-expressed and differentiation was monitored. It was observed that the
GFP over-expression resulted in ~12% of cyst formation, which was similar to the
parental strain, suggesting that differentiation was not enhanced by an unrelated protein.
This finding confirmed that the increase in differentiation was directly correlated to
TgLDH over-expression.
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Figure 3.6
Differentiation of parasites over-expressing TgLDH by alkaline stress.
Immunofluorescence image shows the cyst structure of the RML2-A strain which was
similar to all other transgenic parasites. The nuclei were stained with Hoechst. The
arrowhead indicates the nucleus of the HFF host cell, while the arrow indicates the nuclei
of the bradyzoites. The recombinant Myc-tagged TgLDH2 was revealed by an anti-Myc
primary antibody and a rhodamine-conjugated sheep anti-mouse secondary antibody.
The cyst structure was revealed using FITC-conjugated Dolichos lectin staining. The
scale represents 15 microns.
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Figure 3.7
Quantification of cyst formation in transgenic and parental parasites.
Quantitative analyses of cyst formation were conducted in the differentiated RML1-B,
RML2-D, RML2-A, and RHΔHX strains. The fraction (%) of vacuoles that formed cysts
was calculated from at least 100 vacuoles and from three independent assays.
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3.4.3

Growth of transgenic parasites under alkaline conditions

To evaluate parasite growth under alkaline conditions, the number of parasites in
each vacuole, after 5 days of culturing in alkaline media (pH 8.2), was counted. Figure
3.8 shows that the parental RHΔHX strain retained a sufficient ability to multiply under
alkaline conditions and formed 2, 4, 8, and 16 parasites per vacuole at 5 days postinfection. The distribution of these vacuoles was almost equal (20-30%). In the clonal
RML1-B and RML2-D strains, the majority (~50-60%) of the vacuoles contained 2
parasites, suggesting that alkaline conditions halted parasite multiplication at an early
division stage. On the other hand, the RML2-A strain exhibited a unique growth pattern
blending the characteristic of the parental parasites in having an even distribution of the
number of vacuoles containing either 2, 4, and 8 parasites per vacuole, but not 16
parasites per vacuole, while having 50-60% differentiated vacuoles.
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Figure 3.8
Growth analyses of Toxoplasma gondii under alkaline conditions.
Comparative growth analyses of parasites that were cultured under alkaline conditions for
5 days is displayed as the fraction (%) of vacuoles containing 2, 4 8, 16, or >32 parasites.
An average of 100 vacuoles was counted for all strains in triplicate.
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3.4.4

Cyst formation of transgenic parasites under tachyzoite conditions

To determine if over-expressing TgLDH1 or TgLDH2 could enhance
differentiation of T. gondii in the absence of a stress, the parasites were grown under
tachyzoite conditions and stained with Dolichos-FITC to measure cyst formation. It was
observed that no cyst structures were formed in all strains, indicating that TgLDH did not
enhance cyst formation under tachyzoite conditions (data not shown).
3.4.5

Cyst formation of transgenic parasites after the removal of stress

It was further determined whether the over-expression of TgLDH1 or TgLDH2
altered the bradyzoite’s ability to reconvert into tachyzoites after the alkaline stress was
removed. Parasites from all clonal strains, along with the parental, RHΔHX, were grown
under alkaline media, as previously described. After 5 days, the parasites were returned
to tachyzoite conditions and grown for 48 hours. The parasites were fixed, and stained
with Dolichos-FITC for visualization of cysts at both time points. It was determined that
both parental and transgenic clones could successfully reconvert into tachyzoites after 48
hours. After 5 days in alkaline media, RHΔHX formed 18.3 ± 4.2% cysts. When
reintroduced back into tachyzoite conditions for 48 hours, a total of 7.2 ± 0.2% of
vacuoles remained encysted, indicating that some vacuoles were unable to revert into
tachyzoites. On the other hand, after 5 days in alkaline media, transgenic clones formed
an average of 49.6 ± 3.8% cysts.

After being reintroduced back into tachyzoite

conditions for 48 hours, 8.5 ± 0.3% of vacuoles remained encysted (Fig. 3.9). Therefore,
although TgLDH1 or TgLDH2 over-expression may play a role in enhancing the
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differentiation process under stressful conditions, it does not cause the parasites to remain
encysted after the stress is removed.
Overall, all clonal parasites expressing either of the recombinant TgLDH proteins
could easily differentiate and slowly multiply in comparison to the parental parasite under
alkaline conditions. Also, the majority of the bradyzoites were able to reconvert into
tachyzoites once the stress was removed. These findings suggest that TgLDH plays an
important role in the differentiation process of Toxoplasma gondii.
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Figure 3.9
Cyst formation after removal of stress. Quantification of cysts after
culturing in alkaline media for 5 days, and returning the parasites to tachyzoite conditions
for 48 h. An average of 100 vacuoles was counted in triplicate. The average values for
RML1-B, RML2A and RML2-D are shown as transgenic clones.
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PART II: The role of argonaute in Toxoplasma gondii
3.5

Over-expression of T. gondii argonaute fused to a cherry fluorescent protein
To investigate the physiological function of TgAgo, four strains of parasites were

used: (i) the parental RH and RHΔHX strains, (ii) a previously characterized TgAgo null
mutant (obtained from Dr. Boothroyd, Stanford University School of Medicine), and (iii)
a transgenic line constitutively over-expressing a TgAgo_ChFP fusion.
To detect the presence and level of TgAgo_ChFP in T. gondii, western blot
analysis was used. Since cherry fluorescent protein is a derivative of the red fluorescent
protein (RFP), the antibody against RFP was used to detect the fusion. The molecular
weight of TgAgo is ~58.5 kDa, while that of ChFP is ~27 kDa, generating a fusion
product of ~85.5 kDa, which was detected on the blot. The lysate of the parental RH
parasite was used as a negative control, while a GFP_ChFP fusion protein was used as a
positive control and was detected at ~54 kDa (Fig. 3.10). A band at ~85 kDa was
revealed only in the TgAgo_ChFP parasites, but a band at ~27 kDa was also seen
indicating that degradation or cleavage of ChFP had occurred.
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Figure 3.10 Expression of TgAgo_ChFP in transgenic parasites. Western blot
analysis was used to detect the TgAgo_ChFP fusion protein revealed by an anti-RFP
antibody. RH parasites were used as a negative control, while GFP_ChFP was used as a
positive control. The estimated sizes are indicated on the right.
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Following identification of the fusion protein by western blot analysis,
fluorescence microscopy was used to verify that the fusion protein was producing cherry
fluorescence and that the localization of the fusion was similar to argonaute proteins in
other organisms. Upon monitoring cherry fluorescence, it was observed that the protein
localized mainly to the cytosol when compared to Hoechst staining of the nuclei, which is
in agreement with previous studies (Fig. 3.11; Sen and Blau, 2005).
Furthermore, mass spectrometry was utilized to unambiguously identify the fusion
protein. The lysate containing the fusion protein was electrophoresed and electroblotted
onto a PVDF membrane and the band was identified by a colorimetric substrate of
horseradish peroxidase (HRP).

The band was excised, digested with trypsin, and

analyzed by mass spectrometry (data not shown). The identification of the peptides was
not clear since many of the peptides were the same size as autolysis peaks of trypsin.
There were a few bands that seemed promising; however the amount of protein present
was limited so the protein identification was not sufficient to fully confirm the fusion.
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Figure 3.11 Expression and localization of TgAgo_ChFP in tachyzoites.
Fluorescent microscopy was used to detect TgAgo_ChFP in the tachyzoite parasites.
The nuclei of the parasites were stained with Hoechst. The scale represents 10 microns.
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3.6

Interconversion ability of Toxoplasma gondii strains with altered TgAgo
expression
Database mining for TgAgo revealed that the expression of TgAgo in type I

parasites is elevated as compared to type II based on mRNA expression profiles (Fig.
3.12). This observation led to the hypothesis that argonaute may play a role as a negative
regulator in the differentiation process since type I parasites differentiate less than type II.
That is, higher levels of argonaute may decrease the ability of the parasite to differentiate
into bradyzoites. This hypothesis was tested by comparing the differentiation ability of
transgenic parasites containing TgAgo_ChFP with the knockout (AgoKO) strain and
parental parasites under alkaline conditions.
Immunofluorescence assays were used to monitor cyst formation in all the strains,
where the cyst wall was detected by the FITC-conjugated Dolichos lectin. Many cyst
structures were detected in both the over-expressed TgAgo_ChFP clonal strain and the
AgoKO strain when compared to a parental, RHΔHX, strain (Fig. 3.13). Cyst formation
was quantified by counting the number of vacuoles that formed cysts under tested
conditions in all three strains (Fig. 3.14). The parental strain formed ~14% of cysts,
whereas the AgoKO strain formed ~70% of cysts, and the transgenic clone formed ~40%
of cysts. Therefore, TgAgo may play a role in the interconversion process, but the
definition of that role is still unknown.

70

Figure 3.12 Expression profile of TgAgo. The mRNA levels of TgAgo were
determined by microarray analyses in all three types of parasites. This data was provided
to ToxoDB pre-publication by Paul Davis and David Roos (http://toxodb.org; Oct. 2008).
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Figure 3.13 Differentiation of parasites with altered TgAgo levels. Parasites were
cultured for 5 days under alkaline conditions and subjected to immunofluorescence
assays. Cysts are revealed by Dolichos-FITC, nuclei are revealed using Hoechst staining,
and TgAgo_ChFP was identified by the cherry fluorescence. The scale represents 20
microns.
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Figure 3.14 Quantification of cyst formation in strains with altered TgAgo levels.
Quantitative analyses of cyst formation were conducted for the differentiated
TgAgo_ChFP, AgoKO, and RHΔHX. The fraction (%) of vacuoles that formed cysts was
calculated from at least 100 vacuoles and from three independent assays.
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3.7

The role of TgAgo in an RNA interference-like pathway
The discovery of an argonaute gene in T. gondii has suggested that an RNAi-like

pathway exists in the parasite, and early experiments have shown that gene knockdown is
observed upon introduction of double stranded RNA specific to the UPRT and HXGPRT
genes (Al-Anouti et al., 2004). To determine if argonaute plays a specific role in this
knockdown phenomenon, the following studies aimed to monitor any changes in gene
knockdown ability when argonaute is either over-expressed or knocked out relative to a
parental control.
3.7.1 Measuring RNAi activity in RH parental parasites
To determine the maximum knockdown that could be observed in T. gondii, RH
parental parasites were used as a positive control. UPRT dsRNA was generated and
increasing amounts were electroporated into parasites that were infected onto HFF
monolayers. After 24 hours, radioactive uracil was added to the media, parasites were
grown for another 4 hours, and the amount of incorporated radioactivity was measured. If
knockdown of UPRT was successful, then the parasites would lose the ability to
incorporate radioactive uracil. As a control, the ability of parasites to incorporate uracil
was measured in parasites that were electroporated with 0 μg of dsRNA and the resulting
level of radioactivity was set as 100%. Figure 3.15 shows that the introduction of ~22 µg
of RNA by electroporation resulted in a maximum knockdown of ~60%. Any increase in
RNA concentration greater than 22 µg caused a plateau effect.
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Figure 3.15 RNA interference assay of RH parental parasites with a range of
dsRNA concentrations. Knockdown of UPRT was measured using radioactively
labelled uracil. Increasing amounts of UPRT dsRNA was electroporated into RH
parasites and the percentage of knockdown is shown as compared to control with 0 μg
dsRNA. The experiment was repeated in triplicate and the values are given with their
standard deviations.
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3.7.2

Measuring RNAi activity in parasites containing altered levels of
TgAgo

To determine if TgAgo plays a role in the gene knockdown phenomenon observed
in T. gondii, the UPRT dsRNA was electroporated into both the AgoKO and
TgAgo_ChFP transgenic parasite lines, and the knockdown was measured using
radioactive uracil as previously described. As expected, the AgoKO line showed no
ability to cause knockdown of UPRT (Fig. 3.16A). The amount of uracil that was
incorporated was similar to the control parasites that did not contain dsRNA.
Unexpectedly, the TgAgo_ChFP transgenic line also showed an inability to cause gene
knockdown of UPRT (Fig 3.16B). Similar to the AgoKO strain, the TgAgo_ChFP strain
had values close to control with increasing dsRNA concentrations.
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A

B

Figure 3.16 RNAi activity of parasites with altered levels of TgAgo. Double
stranded UPRT was electroporated into (A) AgoKO and (B) TgAgo_ChFP, and an RNAi
assay was performed using radioactively labelled UPRT. The percentage of knockdown
as compared to control is shown relative to the amount of UPRT dsRNA electroporated.
The experiment was repeated in triplicate and the values are given with their standard
deviations.
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3.8

The effect of altered TgAgo expression on levels of putative dicer proteins
In order to study if the alteration of TgAgo expression affected the levels of

putative dicer proteins, western blot analysis was conducted. Putative dicer proteins were
revealed using an antibody created against a conserved peptide sequence of the RNaseIII
domain of dicer (rabbit anti-RNaseIII). Figure 3.17A shows 3 reactive bands when
probed with anti-RNaseIII at ~120, ~70, and ~40 kDa. RH parasites were used as a
control for natural protein levels. The levels of the 3 bands were quantified against those
of tubulin (Fig. 3.17B). When over-expressing TgAgo_ChFP, there is a slight increase of
the ~120 kDa band from levels in RH, but a drastic decrease in the AgoKO strain. When
comparing the ~70 kDa band, the levels in RH are higher than in the other two strains,
with AgoKO having the lowest levels. Alternatively, when comparing the ~40 kDa band,
the levels in RH are the lowest of the three strains, with AgoKO having the highest levels.
These results suggest that putative dicer proteins may be up-regulated or down-regulated
depending on expression of TgAgo.
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A

B

Figure 3.17 Expression of RNaseIII containing proteins in strains with altered
TgAgo levels. (A) Western blot analysis of RH, TgAgo_ChFP, and AgoKO strains with
anti-RNaseIII antibody. Tubulin was used as a loading control, and approximate sizes are
indicated on the right. (B) Quantitative analysis of putative dicer proteins as compared to
tubulin was obtained by densitometry for all three strains.
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To identify the putative dicer bands, immunoprecipitation (IP) reactions were
performed using anti-RNaseIII bound to protein-A agarose beads. The process consisted
of a pre-clearing step to remove non-specific proteins that bind to the protein-A agarose.
Figure 3.18 shows the coomassie stain of the pre-clear and IP samples. Many bands were
observed in the pre-clear sample, while only the heavy chain of the antibody was
observed in the IP sample. After western blot analysis using anti-RNaseIII (Fig. 3.18),
two bands were revealed at ~40 and ~120 kDa in both the pre-immune sample and RH
lysate that was used as a positive control. In the IP sample, a thick band was observed at
~55 kDa that was specific to the heavy-chain of the antibody, but no bands specific to
anti-RNaseIII were observed. This suggests that the protein was bound to the beads, and
removed in the wash steps. Therefore, the ability to pull-down and identify putative dicer
proteins was not successful. Thus, further optimization of the experiment is necessary to
successfully characterize the putative dicer proteins.
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A

B

Figure 3.18 Identification of putative dicer proteins by immunoprecipitation.
Immunoprecipitation was used to pull-down putative dicer proteins by the anti-RNaseIII
antibody bound to protein-A agarose beads. (A) A coomassie stain shows many bands in
the pre-clear sample, while only the heavy-chain of the antibody is seen in the IP sample.
(B) Western blot analysis with anti-RNaseIII indicates that putative dicer proteins were
observed in the pre-clear sample that were similar to the RH lysate sample, however no
bands were pulled down in the IP sample. Approximate sizes are indicated on the right.
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Chapter IV
Discussion and Future Work
Toxoplasma gondii is a widespread pathogen that infects approximately one-third
of the world’s population. Typically asymptomatic in healthy individuals, T. gondii can
remain dormant for the lifespan of the host as encysted bradyzoites. However, if the host
becomes immuno-compromised due to illness such as AIDS, T. gondii can reconvert from
its dormant stage into the highly virulent tachzyoite stage and cause a recurrence of
infection that may prove fatal (Ferguson et al., 2002; Lindsay et al., 1991; Luft and
Remington, 1992). The interconversion between bradyzoites and tachzyoites is thought
to be an important process in the pathogenesis of the parasite; however studies of the
process have proven unsuccessful in determining the mechanisms behind interconversion
and thus remains poorly understood (Reiter-Owona et al., 2000). The current studies
have focused on lactate dehydrogenase and argonaute, and the roles they may play in this
process.

Elucidation of the mechanism of interconversion may eventually lead to

development of possible drug targets that would prevent the parasite from entering a
dormant stage, thus preventing chronic toxoplasmosis.
Previous studies on T. gondii lactate dehydrogenase indicated that knockdown of
TgLDH resulted in variable growth rates under both tachyzoite and bradyzoite conditions.
More importantly, the differentiation ability was impaired in vitro and the parasites were
unable to form tissue cysts in a murine model system. The parasites in the mice were not
as virulent, and the mice survived a challenge with parental parasites that would typically
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cause 100% mortality. These results suggested that TgLDH is important for both the cell
cycle and differentiation ability of T. gondii (Al-Anouti et al., 2004). Therefore, it was of
interest to study the effect of over-expressing TgLDH in tachyzoites, and measuring the
resulting phenotypes in relation to growth and differentiation ability.
Furthermore, it was also of interest to study the role of the argonaute protein in a
putative gene knockdown pathway.

In other organisms, posttranscriptional gene

silencing, known as RNA interference, has offered insight into the importance of the
pathway, as well as provided a genetic tool for studying the organism. The identification
of T. gondii argonaute, and the knockdown phenomenon generated by introduction of
dsRNA leads to speculations that an RNAi-like pathway exists in T. gondii (Al Riyahi et
al., 2006). Thus, current studies aimed to measure the effect of differentially expressing
TgAgo on the knockdown phenomenon, to better understand the phenomenon within the
parasite. Moreover, argonaute proteins have been identified as key players in other
cellular functions in many organisms (Carmell et al., 2002; Jaronczyk et al., 2005).
Therefore, the studies also revolved around the parasites ability to successfully
differentiate in vitro upon the over-expression or knockout of TgAgo.

4.1

Validation of parental parasites as type I parasites
In order to further characterize the role of TgLDH’s in T.gondii, transgenic lines

over-expressing Myc-tagged TgLDH1 and Myc-tagged TgLDH2 were generated. The
parental parasites, RH and RHΔHX, used for generation were first subjected to
genotyping studies to ensure that there was no contamination with any type II parasites
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that may have occurred during routine culture. This was important because the present
studies involved the formation and quantification of bradyzoites in vitro, and since type II
parasites have an increased ability to differentiate, any contamination would have skewed
the results (Sibley and Boothroyd, 1992).
Single nucleotide polymorphisms (SNPs) are DNA sequence variations where one
basepair in the genomic sequence is altered between different strains or types of an
organism. These SNPs allow for genotyping studies that involve restriction fragment
length polymorphisms. In this case, sequences of the genome that contain SNPs are
amplified by PCR, and further digested using restriction endonucleases. Since one type
of the parasite will contain the correct restriction site, digestion will occur. However, the
presence of an SNP in another type of parasite will eliminate the restriction site thus
preventing digestion. This results in varying digestion patterns in differing types of
parasites. Two genes, GRA6 and SAG2, have been shown to contain SNPs, and were
thus used in these studies to validate the typing of the parasite (Fig. 3.1). The resulting
banding patterns were compared with those identified for type I and type II parasites and
it was concluded that only type I parasites were present (Khan et al., 2005). Since
differentiation studies revealed a relatively high number of cyst structures in parental
parasites when using alkaline media, as compared to the low values found in literature
(Radke et al., 2006), it suggests that these parasites have type II characteristics.
However, since genotyping confirmed the parasites as type I, the high values were
possibly due to the method of quantification. Since the same method of quantification
was used for all experimental strains, the values were comparable to each other.
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4.2

Transgenic parasites over-expressing TgLDHs were successfully generated
T. gondii lactate dehydrogenase (TgLDH) is an important enzyme in the

glycolysis pathway that catalyzes the interconversion of pyruvate to lactate. After an
immune response, the parasites differentiate into bradyzoites, which are the slowly
multiplying, encysted form that primarily utilize glycolysis for energy production. To
study the importance of TgLDH’s on bradyzoite formation, transgenic parasites overexpressing either TgLDH1 or TgLDH2 were used. The clonal parasites were analysed by
western blot analysis for the presence of TgLDH (Fig. 3.2A). The clonal parasites
expressed either TgLDH1 (~39 kDa) or TgLDH2 (~40 kDa) whose larger sizes
corresponded to addition of the Myc-tag. The light bands found in the anti-LDH2 panel
were the residual signals resulting from successive anti-Myc and anti-LDH2 antibody
incubations. The blot was first revealed using an anti-Myc antibody and then stripped
prior to anti-LDH2 incubation (Fig. 3.2A).
The levels of over-expressed TgLDHs in all clones were quantified against those
of tubulin (Fig. 3.2B). Between the clonal TgLDH1 strains, RML1-A exhibited a higher
level of recombinant TgLDH1 than RML1-B.

Among the clonal TgLDH2 strains,

RML2-C exhibited the lowest amount of recombinant TgLDH2 and RML2-A and RML2D had the highest levels. It was noted that there was no direct relationship between the
level of recombinant protein expression and the endogenous level of TgLDH1 expression.
That is, varying amounts of over-expressed protein was observed that did not depend on
or relate to endogenous levels of TgLDH1. The varied levels of recombinant TgLDH1
and TgLDH2 expression in the clonal strains might be the result of the integration
frequency and location where the random gene integration took place, which is quite
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common in T. gondii (Donald et al., 1996; Striepen et al., 1998). If there was a higher
frequency of integration in one clone versus another, the levels of over-expression would
have increased regardless of endogenous levels of TgLDH1. It is also important to note
that if random integration had occurred within a genomic sequence coding for a specific
gene, the phenotypes observed may result from the loss of a different gene. However,
this is unlikely since the possibility of the integration interrupting the same gene in each
clone is improbable, and so the same phenotype that was observed in multiple clones is
likely due to TgLDH over-expression. It was also noted that no endogenous levels of
TgLDH2 appeared when probed with anti-LDH2, thus ensuring that the parasites were in
fact in the tachzyoite stage and not in the bradyzoite stage. Furthermore, the level and
localization of the over-expressed proteins in tachyzoites was detected by
immunofluorescence assays (Fig. 3.3). Only clone RML1-B is shown, however all other
clones exhibited the same result.

The over-expressed proteins were revealed using

rhodamine-conjugated mouse anti-Myc so that the over-expressed proteins, in particular
TgLDH1, could be identified apart from endogenous TgLDH1. It was observed that the
over-expressed proteins could successfully be revealed with anti-Myc and that the
localization was in the cytosol, which is in agreement with previous studies (Ferguson et
al., 2002).
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4.3

TgLDH over-expression did not alter the overall TgLDH enzymatic activity
or growth of parasites under tachyzoite conditions
Due to the distinctive over-expression, it was expected that a change in the overall

TgLDH enzymatic activity would occur. The enzymatic activity was determined by
measuring the absorbance of NADH after addition of pyruvate to lysates which were
compared to parental and host cell controls. Unexpectedly, neither an increase nor
decrease in overall TgLDH activity was detected (Table 3.1). It has been suggested that
the active TgLDH enzyme is formed upon the assembly of a homotetrameric complex
(Dando et al., 2001). If the recombinant proteins were non-functional, due to mis-folding
or mutations, the proteins would have interfered with the assembly of wild-type TgLDH
complexes and would have decreased the overall TgLDH activity. It is also likely that the
mis-folded proteins would have been degraded and given rise to truncated and unstable
forms of the recombinant proteins. If this was the case, multiple bands with varying
molecular weights would have been detected during western blot analyses. However,
only single bands were detected when either the anti-Myc or anti-TgLDH antibodies were
used (Fig. 3.2A) suggesting that stable proteins were present. On the other hand, if the
recombinant proteins were functional and able to form ternary complexes, an increase in
the overall enzymatic activity would have been observed. However, since an increase
was not observed, it is possible that the recombinant proteins were sequestered upon overexpression and thus were unable to participate in formation of homotetrameric
complexes. This sequestering phenomenon has been observed in many organisms upon
over-expression of proteins, in particular, the formation of inclusion bodies in bacteria is
quite common and leads to inactive proteins (Kiefhaber et al., 1991; Mukhopadhyay,
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1997).

If sequestered, the recombinant proteins would have been protected from

degradation as well as from the formation of active ternary complexes, while still
remaining in the cytosol (Fig. 3.3) and maintaining the enzymatic activity as seen in
parental.
The growth of the transgenic tachyzoites was monitored at 24 and 48 hours postinfection from parasites that underwent less than three passages (early) or six passages
(late) in culture (Fig. 3.4 A-D) to ensure that long passage in culture did not alter the
expression of recombinant proteins and hence the effect of these proteins as suggested by
Van et al. (2007). It was observed that the growth of the parasites from early and late
passages was unaffected and mirrored the growth of the parental strain. The finding that
the growth and enzymatic activity were unaffected with over-expression of either
TgLDH1 or TgLDH2 suggests that the proteins did not increase the rate of glycolysis and
energy production which would be associated with a higher growth rate. Thus, it is likely
that the proteins are playing a different role within the parasites.

4.4

The over-expression of TgLDHs increases differentiation under alkaline
media stress
The conversion between the rapidly dividing tachyzoites and the slowly growing,

encysted bradyzoites is an important event in the parasite life cycle. TgLDH1 and
TgLDH2 proteins have been used as markers for tachyzoites and bradyzoites, respectively
(Weiss and Kim, 2000; Yang and Parmley, 1997). The TgLDH1 mRNA is still present in
bradyzoites, however the protein is replaced by TgLDH2. Thus, it was important to study
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the effect of TgLDH1 and TgLDH2 over-expression on differentiation. Since the process
of differentiation is poorly understood, it was necessary to verify that the observed cyst
formation correlated to the presence of bradyzoite markers. The bradyzoite specific
antigen-1 (BAG1) was used as a control for bradyzoite formation (Bohne et al., 1995),
and tubulin was used as a loading control. As a positive control, the PLKΔHX strain was
used, which is a type II laboratory strain that has a greater ability to differentiate as
compared to type I parasites. The RML2-mix strain is the original strain that was
electroporated with TgLDH2, and used to clone individual parasites. This strain was used
as a test for differentiation. Western blot analysis indicated that the marker appeared in
bradyzoite samples that were grown in alkaline media for 5 days and was not present in
tachyzoite samples (Fig. 3.5). This indicated that when levels of cysts were visualized in
transgenic parasites, the results correlated to bradyzoite formation.
A fluorescently labelled (FITC) Dolichos-lectin was used to monitor cyst
formation (Fig. 3.6), which exhibited similar characteristics as observed by Dzierszinski
et al. (2004).

Cyst formation was quantified by manually counting the number of

vacuoles that formed cyst walls (Fig. 3.7). It was observed that transgenic parasites overexpressing either TgLDH1 or TgLDH2 formed nearly 50% more cyst structures than the
parental RHΔHX. Over-expressing an unrelated GFP protein produced ~12% of cyst,
suggesting that the increased differentiation was a direct result of over-expressed
TgLDHs. Furthermore, the growth of parasites under alkaline conditions was halted in
the transgenic clones, which is characteristic of cyst formation (Fig. 3.8). It is not
understood, however, why both TgLDH1 and TgLDH2 have a similar effect on the
parasite’s ability to differentiate.

It is likely that post-transcriptional regulation is
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important for the temporal and spatial regulation of TgLDH’s and over-expression may
cause interference in this regulation. Also, it is not known if differentiation causes the
regulation of TgLDH’s or if the regulation affects the differentiation process. By testing
the parasite’s ability to spontaneously form cysts, without any alkaline stress, it was
determined that the regulation likely relies on the differentiation process since an increase
in spontaneous cyst formation was not observed. Also, the parasite’s ability to convert
back into tachyzoites once the stress was removed further suggests that TgLDHs may
play a role in increasing cyst development under stress, but do not cause the parasites to
remain encysted (Fig. 3.9). It is important to note that the parental parasites form almost
20% of cysts after 5 days in alkaline media. After the parasites are returned to tachyzoite
conditions for 48 hours, ~8% of vacuoles are still encysted. Transgenic parasites, on the
other hand, formed nearly 50% of encysted vacuoles after 5 days in alkaline media. Once
again, after returning the parasites to tachyzoite conditions for 48 hours, ~10% of
vacuoles remain encysted. Therefore, the presence of either over-expressed TgLDH1 or
TgLDH2 increased the rate of reconversion from bradyzoites to tachyzoites. Thus, not
only is the conversion into bradyzoites increased under stress, but the reconversion into
tachyzoites once the stress is removed is also increased.
In conclusion, these studies are the first to suggest an important physiological
function of TgLDH, in addition to being a glycolytic enzyme. To further determine the
domains responsible for the function, one would perform deletion studies in which the
substrate-, coenzyme-binding domains, or other truncated proteins can be assayed for
their effects on the differentiation efficiency. Also, immunoprecipitation assays could be
performed to detect any proteins that the TgLDHs are interacting with to attempt to
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elucidate any other pathways in which TgLDHs may have roles. Finally, it would be
interesting to measure the ability of these transgenic parasites to infect mice and form
tissue cysts, to determine the differentiation ability in vivo.

4.5

TgAgo_ChFP was successfully generated and localized
The discovery of Toxoplasma gondii argonaute (TgAgo; Al Riyahi et al., 2006)

suggested that there may be a functional RNA interference (RNAi) pathway within T.
gondii. It is also likely that TgAgo may play a role in other cellular functions in T. gondii
as it does in many organisms (Carmell et al., 2002; Jaronczyk et al., 2005). To study the
role of TgAgo, a fusion with cherry fluorescent protein (ChFP) was generated (Appendix
A). ChFP was derived from a red fluorescent protein as a monomeric protein that excites
at 587 nm and emits at 610 nm. The benefits of using ChFP rather than GFP or RFP are
that ChFP has a fast rate of maturation, high photostability, resistance to pH changes, and
the ability to form stable N-terminal fusions within a cell (Shaner et al., 2004).
Therefore, localization of TgAgo in the parasites is not likely to be compromised by the
presence of ChFP.
Parasites harbouring the TgAgo_ChFP fusion were identified both with western
blot analyses and by fluorescence microscopy. The anti-RFP antibody was able to be
utilized since the ChFP protein is derived from RFP and the antibody was shown to cross
react. The western blot revealed a band at ~85 kDa as was expected since the molecular
weight of TgAgo is ~58.5kDa, while that of ChFP is ~27kDa (Fig. 3.10). There were two
bands that were visualised for the TgAgo_ChFP sample that were nearly the same size. It
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is possible that the faint higher band is a phosphorylated form of TgAgo. It has been
shown that phosphorylation of human argonaute 2 plays a regulatory role in localizing
argonaute 2 into processing bodies where degradation of messenger RNA occurs (Zeng et
al., 2008).

Further studies of TgAgo would have to be performed to determine if

phosphorylation is occurring for example by utilizing antibodies specific to
phosphorylated forms of proteins. On the other hand, the band shift may also be the
result of a modification of ChFP or a possible degradation form of the fusion; however
degradation is unlikely since the difference in size is minimal. Fluorescence microscopy
indicated that TgAgo_ChFP localizes mainly to the cytosol when compared to staining of
the nuclei. This finding is in agreement with localization studies of argonaute in other
organisms. The proper localization suggests that TgAgo_ChFP functions appropriately
since it has been shown that localization is related to function (Sen and Blau, 2005). The
expression level and localization of the fusion protein could not be related to endogenous
levels of argonaute due to a lack of antibody towards the endogenous protein.
Further characterization of TgAgo_ChFP was attempted by using mass
spectrometry. The lysate of transgenic parasites was run on a western blot, transferred to
a PVDF membrane, and the band corresponding to TgAgo_ChFP was excised and trypsin
digested. Unfortunately, the autolysis peaks of trypsin overlapped with peptide masses of
TgAgo_ChFP, so identification was unsuccessful. In order to properly utilize mass
spectrometry, another enzyme, such as GluC, could be used for digestion to avoid the
overlapping of peaks. These peak sizes would differ since GluC cleaves after glutamic or
aspartic acid residues, unlike trypsin which cleaves after lysine and arginine residues, thus
these peaks would not overlap with important TgAgo_ChFP peaks. Another possibility is
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to enrich for the protein of interest by immunoprecipitation. This would increase the
amount of protein available for digestion by proteases. If the number of generated
peptides is increased, then the intensity of trypsin autolysis peaks decreases, allowing for
isolation of specific peptides of interest and identification of the amino acid sequences.
Immunoprecipitation of TgAgo_ChFP was attempted using the anti-RFP antibody bound
to protein-A agarose beads, however the binding between the antibody and protein is
weak, thus preventing successful immunoprecipitation. Preliminary data suggested that
either no protein bound, or very low levels bound (data not shown). The former is more
likely since silver staining of the SDS-PAGE gel did not show a band appearing at the
expected size and this method of staining is very sensitive where its detection is in the
nanogram scale (Chevallet et al., 2006).

4.6

Differential expression of TgAgo alters the interconversion ability of T. gondii
Database mining revealed that mRNA levels of TgAgo vary among the three types

of parasites, wherein type I parasites contain the highest levels of TgAgo (Fig. 3.12).
Since type I parasites do not differentiate very well, it was hypothesized that TgAgo may
play a role as a negative regulator of the process. That is, higher levels of TgAgo may
somehow prevent the parasite from successfully differentiating into bradyzoites. This
hypothesis was tested by studying the differentiation ability of three strains of parasites:
transgenic parasites over-expressing TgAgo_ChFP, a null mutant of TgAgo (AgoKO),
and a parental RHΔHX strain. It was observed that both the TgAgo_ChFP and AgoKO
strains could differentiate more than RHΔHX. The cyst structures observed with FITCconjugated Dolichos-lectin are similar to the cyst structures observed in over-expressed
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TgLDH parasites (Fig. 3.6 and 3.13). Quantification of the cyst structures was performed
as previously described, and showed that AgoKO parasites formed ~65% of cysts versus
~14% in the parental RHΔHX (Fig. 3.14). This result suggests that TgAgo plays a
significant role by preventing parasites from differentiating. One concern is from the
generation of the AgoKO strain. The TgAgo genomic sequence is ~4,500 bp in length.
In order to generate the knockout, approximately a 6.5 kb region of sequence was deleted.
A putative long chain fatty acid CoA ligase gene and two hypothetical proteins are
located on either end of TgAgo. Deletion of any part of these genes may be attributed to
the phenotypes observed.

Therefore, these studies must be performed in another

knockout strain to be generated by deleting a smaller fragment of TgAgo which would
ensure that no other putative or hypothetical genes are interrupted.
It was unexpected that the over-expression of TgAgo_ChFP formed just under
40% of cysts that correlate with cherry fluorescence (Fig. 3.13, 3.14). Moreover, it was
expected that over-expression of the fusion would result in the differentiation ability to
resemble or be lower than parental levels. These results suggest that over-expressing
TgAgo may somehow counter-effect the protection against cyst formation. It is possible
that the large ChFP tag may interfere with proper TgAgo function if it interrupts proper
associations with other proteins, thus causing differentiation to increase. Furthermore,
recent database mining has revealed new available data for microarray studies of TgAgo
that show similar levels of TgAgo between type I and type II parasites (http://toxodb.org;
April 2009), as opposed to the higher levels in type I that were observed in previous
database mining efforts.

These new experiments had used two different strains of

parasites for each type to show reproducibility within a lineage. Also, these experiments
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were performed with better controls in that all parasites were harvested together at a
similar confluency, the RNA samples were prepared at the same time, and all
hybridizations were performed by one technician. The current studies were based on the
previous microarray results that suggested that TgAgo may play a role in differentiation.
The altered differentiation ability that was observed between the mutant TgAgo strains
fits the initial hypothesis. Thus although the new data indicates that levels of TgAgo do
not actually differ, TgAgo likely has a role in the pathway. To further validate the levels
of TgAgo mRNA, real time PCR should be performed so that more definitive correlations
between TgAgo expression and differentiation can be made.

4.7

Argonaute plays a role in a putative gene knockdown pathway in T. gondii
Identification of key players of the RNA interference pathway in the

apicomplexan T. brucei led to elucidation of a similar pathway in T. gondii. Recently, an
argonaute protein was identified in T. gondii, and gene knockdown was observed after
introduction of double stranded RNA (Al-Anouti et al., 2004). It was of interest to
identify a direct correlation between TgAgo and dsRNA induced gene knockdown. The
over-expressed and knockout lines of TgAgo were utilized to determine if the ability to
knockdown UPRT was affected. RH parasites were used as a control for knockdown
levels, and it was determined that a maximum knockdown of ~60% was observed when
using ~20 µg of dsRNA (Fig. 3.15). The same experiment was repeated using the
AgoKO and TgAgo_ChFP strains where a range of dsRNA concentrations were
electroporated into the parasites. It was observed that no significant knockdown was seen
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in either strain (Fig. 3.16). Knockout or knockdown of argonaute in other organisms
resulted in a large reduction of RNAi activity suggesting that argonaute plays a key role
in RNAi (Durand-Dubief and Bastin, 2003). The lack of RNAi activity in the AgoKO
strain suggests that TgAgo also plays a key role in the gene knockdown pathway of T.
gondii. If the knockdown had been a result of non-specific degradation, then knocking
out TgAgo would not have affected the results. However, since knockdown was no
longer visible in the AgoKO strain, it is suggested that TgAgo plays a role and the
degradation is sequence specific. In the over-expressed strain, an inability to successfully
knockdown UPRT was also observed. It is possible that the large cherry tag interferes
with RISC formation that may be required for a functional RNAi pathway. To overcome
this problem, a different tag such as a Myc or FLAG tag should be used that is smaller in
size and would not interfere with protein-protein interactions. An N-terminal fusion that
contains the cherry fluorescent protein on the N-terminal of TgAgo was generated to
determine if the position of cherry caused the fusion to act as an inhibitory protein in
proper RISC formation (Appendix C). Therefore, this fusion should be tested in the
future in its ability to differentiate and perform double stranded induced gene silencing.
It would also be interesting to determine if the observations made in these studies are the
direct result of altered levels of endogenous argonaute. Several clones of the fusion
parasite should be tested since random integration may interfere with other genes causing
some of the mentioned phenotypes. Thus it is necessary to ensure that the results with the
fusion strain were not merely artifacts.

4.8

Altered levels of TgAgo affect the expression levels of putative dicer proteins
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It was of interest to determine if the expression of putative dicer proteins differed
in parasites that had altered TgAgo levels. To do so, an antibody raised against the
RNaseIII domain of dicer was used in western blot analysis (Fig. 3.17). It was observed
that the expression of two putative dicer proteins at ~120 kDa and ~70 kDa was
downregulated in the AgoKO strain, while expression of a putative dicer protein at ~40
kDa was upregulated in the AgKO strain, as compared to parental. These results suggest
that the proteins may be involved in the same pathway since expression of one affects the
expression of the other, or that upregulation of an RNaseIII domain containing protein is
compensating for the loss of argonaute. Full identification of the putative dicer proteins
was attempted by immunoprecipitation assays which would be used in conjunction with
mass spectrometry, unfortunately, very low levels were observed in the pre-clear sample
and no proteins were pulled down (Fig. 3.18). Optimization and possible enrichment
experiments are required in further analyses to elucidate the proteins and their functions.
Also, putative dicer proteins, as detected by database mining can be cloned and overexpressed in T. gondii to measure the resulting phenotypes to further determine if the
protein products participate in an RNAi-like mechanism.

4.9

Conclusions
Studies of the pathologically important T. gondii focused on the lactate

dehydrogenase enzyme in the interconversion pathway, and on argonaute’s possible role
in both interconversion and gene knockdown. It was observed that although the overexpression of TgLDH1 or TgLDH2 did not change the overall enzymatic activity,
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increase growth of tachyzoites, or yield a more virulent parasite strain, a significant in
vitro differentiation to bradyzoites was detected after increased TgLDH1 or TgLDH2
expression. It was also observed that TgAgo may play a role in differentiation since misregulation of the protein expression results in an increase in bradyzoite formation.
Finally, the knockout of TgAgo failed to produce an RNAi response suggesting that
TgAgo plays a critical role in the pathway since the pathway cannot occur without its
presence. The lack of gene knockdown in the over-expressed TgAgo_ChFP strain may
be due to the large cherry tag interfering with RISC formation, thus halting the process.
Finally, altered levels of argonaute expression significantly alter expression of putative
dicer proteins suggesting that these proteins may participate in the same pathway.
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Appendices
Appendix A
A.1

Generation and identification of Toxoplasma gondii argonaute fused to a cherry
fluorescent protein
In order to study the argonaute protein in Toxoplasma gondii (TgAgo) four strains of

parasites were used: parental RH or RHΔHX strains, a TgAgo null mutant (obtained from Dr.
Boothroyd, Stanford University School of Medicine), and a transgenic line over-expressing
TgAgo_ChFP. The TgAgo_ChFP fusion protein was generated by utilizing a plasmid that
contained the cherry fluorescence protein driven by a T. gondii tubulin promoter
(pTub_eGFP_mChFP). The plasmid was digested with NheI and BglII to excise the GFP
gene. The vector backbone was then extracted from an agarose gel, and used for the ligation
reaction.
A.2

Preparation of TgAgo coding sequence
To acquire the coding sequence of TgAgo containing restriction sites that were

compatible with the vector, the sequence was PCR amplified using oligonucleotides which
incorporated the NheI and BglII sites on either end, and the PCR fragment was ligated into a
pBluescript plasmid. This plasmid was transformed into E. coli cells and used for blue/white
screening to identify clones that contained the target gene. The plasmid was confirmed by
digestion with PvuII and XhoI (Fig. A.1) and further digested with NheI and BglII (Fig. A.1) to
obtain the TgAgo coding sequence which was extracted from an agarose gel, ligated with the
pTub_ChFP vector, and transformed into E. coli. PCR amplification of an 800 bp fragment
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using internal oligonucleotides confirmed the presence of TgAgo in the isolated plasmids (Fig.
A.1).
A.3

Confirmation of the pTubTgAgo_ChFP plasmid by restriction digestion and
DNA sequencing
To ensure that TgAgo had been ligated into the vector in the correct orientation,

restriction digestions were performed using XhoI and PvuII (Fig A.2), which produced the
correct banding patterns. The plasmid DNA was sent to Genome Quebec Innovation Centre
(Montreal, Quebec) for DNA sequencing analysis.
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A

B

C

Figure A.1
Isolation of TgAgo and generation of TgAgo_ChFP. (A) Confirmation of
the pBlueScript_TgAgo plasmid by digestion of the plasmid with PvuII and XhoI. The
undigested plasmid was run as a control. (B) The pBlusk_TgAgo plasmid was doubly
digested with NheI and BglII to isolate and extract the TgAgo coding sequence at 1581 bp
which was further used for ligation reactions. (C) The pTubTgAgo_ChFP plasmid was used
as a template for PCR amplification using internal oligonucleotides that amplify an 800 bp
fragment from TgAgo. The pTubGFP_mChFP plasmid was used as a negative control.
Approximate sizes are indicated on the left.
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A

B

Figure A.2
Confirmation of pTubTgAgo_ChFP plasmid by restriction digestion. (A)
XhoI and (B) PvuII enzymes were used to confirm the construction of the plasmid.
Approximate sizes are indicated on the left. The correct banding patterns were obtained.
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Appendix B

Feature
F1_ORI
Tub8 Eukaryotic Promoter
Myc Epitope Tag
TgLDH1 ORF
SAG1 3’-UTR
TgHXGPRT Cassette
Plac Prokaryotic Promoter
ColE1_ORI
APr CDS

Location (bp)
1 – 457
656 – 1146
1172 – 1201
1246 – 2238
2241 – 2541
2586 – 4467
4534 – 4655
4749 – 5612
5693 – 6550
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Feature
F1_ORI
Tub8 Eukaryotic Promoter
Myc Epitope Tag
TgLDH2 CDS
SAG1 3’-UTR
TgHXGPRT Cassette
Plac Prokaryotic Promoter
ColE1_ORI
APr CDS

Location (bp)
1 – 457
656 – 1146
1172 – 1201
1205 – 2224
2228 – 2528
2573 – 4454
4521 – 4642
4736 – 5599
5680 – 6537
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Feature
(mutated) F1 (+) ORI
APr CDS
ColE1 ORI
(mutated) Plac
SagCATSag cassette
Tub8 Promoter
TgAgo CDS
CherryFP CDS
3’ DHFR UTR

Location (bp)
1 – 457
588 – 1447
1526 – 2389
2483 – 2605
2730 – 4067
4126 – 6842
6832 – 8430
8439 – 9143
9156 – 9908
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Feature
(mutated) F1 (+) ORI
APr CDS
ColE1 ORI
(mutated) Plac
SagCATSag cassette
Tub8 Promoter
CherryFP CDS
TgAgo CDS
3’ DHFR UTR

Location (bp)
1 – 457
588 – 1447
1526 – 2389
2483 – 2605
2730 – 4067
4126 – 6842
6858 – 7565
7576 – 9156
9165 – 9917
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Appendix C

Figure C.1
Identification of an N-terminal fusion of ChFP_TgAgo. Western blot
analysis was used to identify the expression of the N-terminal fusion of ChFP_TgAgo in T.
gondii. The anti-RFP antibody was used to reveal a band at 85 kDa that corresponded to the
fusion. The band at 27 kDa corresponds to a cherry cleavage and RH was used as a negative
control.
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